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                     General introduction 
Physiological functions of HO 
    Iron is a crucial element for a vast number of cellular processes, including ATP 
generation (respiratory chain), oxygen transport (Hb), and detoxification (cytochrome P450). 
It has functions within heme or iron-sulfur clusters, or directly bound to proteins. Disorders 
of iron metabolism are quite common in the human population, for instance, anemia caused 
by the dietary iron deficiency. Normally in humans, about 1 mg of iron is supplied from foods, 
and at the same time an equal amount is eliminated from the body. Remarkably, this dietary 
iron accounts for only 1-3% of the needs of iron. Most of that is provided from the 
degradation of free heme, which is mainly produced by the degradation of senescent 
erythrocytes. Heme oxygenase (HO, EC 1.14.99.3), which was firstly purified and
The porphyrin ring of heme is oxidatively cleaved by HO, producing biliverdin, iron, and 
CO. Biliverdin is further converted to bilirubin by biliverdin reductase. Bilirubin is 
conjugated with glucronic acid by UDP-glucuronyl transferase to increase its solubility 
and then excreted into the bile. 
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characterized by Tenhunen et al. from the microsomal fraction of rat liver and spleen (1,2), 
plays a central role in the heme degradation pathway (Figure 1-1) (3). Iron recovered by HO 
would follow detoxification pathways involving either sequestration by ferritin or 
extracellular efflux by transferrin and lactoferrin. The most important fuction of HO is the 
iron homeostasis. 
    Moreover, two major functions of HO in mammals have been recently proposed; the 
defense for oxidative stress and the production of CO as a signaling molecule (Figure 1-2). 
Two isozymes are known in mammals; HO-1 (33 kD) and HO-2 (36 kD), both of which 
catalyze the same reaction and its mechanism is identical (4), whereas their inducibility and 
organic specifity of expression differ. HO-1 is highly inducible by its substrate, heme, and 
various non-heme substances such as heavy metals, bromobenzene, endotoxin, oxidizing 
agents, cytokines, NO, and UVA (5). HO-1 is mainly expressed in spleen and liver, but this is 
expressed in almost all organs. Thus HO-1 would be mainly involved in heme metabolism 
and defense for oxidative stress (6). Indeed, the deficiency of HO-1 in human causes 
vulnerability to stressful injury (7). The manners for defense against oxidative damage by 
HO-1 are summarized in two points. One is the removal of free heme which activates 
molecular oxygen to free radical through the Fenton reaction. The other is the anti-oxidative 
properties of the product. In mammals, biliverdin IXa is reduced to bilirubin IXa by 
biliverdin IXoc reductase (Figure 1-1). The accumulation of excess bilirubin IXa is caused to 
jaundice, however, up to physiological concentration (about 8.5 µM), bilirubin IXa have great 
anti-oxidative properties. This is more effective than tocopherol (vitamin E) which is regarded 
as the best antioxidant against lipid peroxidation (8,9). Biliverdin IXa also has anti-oxidative 
properties (9). Therefore HO-1 is contributed to the defense for oxidative damage by 
removing free heme, pro-oxidant, and producing bilirubin IXa and biliverdin IXa, 
anti-oxidant. 
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    In addition to the iron homeostasis and defense for oxidative stress, the functions via 
CO, by-product of HO reaction, are supposed for HO-1 that vasodilation, anti-platelet 
aggregation, anti-proliferation, anti-apotopsis, and inhibition of pro-inflammatory cytokine 
production (10,11). Only HO reaction is the known source of endogeneous CO. The 
molecular target of CO is unknown, but two canditates are proposed (Figure 1-2). One is the 
soluble form of guanylate cyclase (sGC), which is activated by NO binding to the heme 
moiety (12). CO can also bind to heme in sGC and can activate although this effect is very 
small compared to NO in vitro. However, it was recently reported that YC-1, which is a small 
artificial compound and has similar structure to biliverdin, can activate sGC bound to CO 
comparable to NO (13). Biliverdin and bilirubin don't have such property, but the unknown 
compound modified from biliverdin may promote the activation of sGC by CO. Another 
target for CO is p38 mitogen activating protein kinase signaling pathway where CO affects to 
the anti-inflammation and anti-apoptosis although the direct target involved in this patyway is 
unknown (10). 
                               Biliverdin reductase Figure 1-2. Summary of 
                       biliverdin -0 bilirubin physiological functionsof
                            Antioxidation HO products. 
                                           The products of HO,
          HO             f- -° biliverdin, Fe +, and CO, are heme Fe2+ Iron homeostasis                                                 i
nvolved in several 
                                              physiological functions. Fe2+;
                                              Iron homeostasis. Biliverdin
                     co and bilirubin; Antioxidation.
                                                CO; second messenger for
                                                  several reactions. 
          zz~~ p38 MAP kinase Guanylate cyclase 
       An at
i            Anti-inflammnflammaton 
                                    GTP cGMP 
                                                   Vasoregulation
                                                 Neurotransmission 
                                                Anti-proliferation
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    HO-2, constitutively expressed in nerve cell and testis, would also function to produce 
CO as a signalling molecule in neuron. But its target is also unknown. In plants and 
cyanobacteria, HO functions to synthesize biliverdin, which is a precursor of open-chain 
tetrapyrrol chromophores, such as phycobilins and phytochromobilins (14). In some 
pathogenic bacteria, HO is involved in iron supply from host (15). 
Reaction scheme of HO 
    One cycle of HO reaction (Figure 1-3, (16-25)) consists of three sequential steps of 
heme oxidation utilizing molecular oxygen and reducing equivalents from 
NADPH-cytochrome P450 reductase (CPR), in mammals (1,26), or ferredoxin, in plants and 
cyanobacteria (27). In this reaction, heme acts as co-factor activating 02 as well as substrate. 
    The notable features of HO reaction are classified into three categories.One is the 
activation mechanism of molecular oxygen bound to the heme iron. Spectroscopic features of 
heme-HO are similar to Mb rather than cytochrome P450, indicative that the electronic 
structure of heme is simiar to that of Mb (28-31). As well known, Mb does not activate 02, 
only binds 02. How does heme-HO activate 02? The mechanism of 02 activation is well 
studied in cytochrome P450; the mechanism, so called "push-pull" mechanism, is the 
combination of electron donation from the proximal ligand (thiol group in cytochrome P450) 
and charge-relay system from 02 to water and distal residues (Figure 1-4) (16). In this 
mechanism, O=O bond is heterolitically cleaved and oxyferryl species is produced. Similar 
mechanism is also believed in peroxidase and other heme containing monooxygenase (16). 
But in HO, oxyferryl species is not produced in the reaction and ferric hydrogen peroxide is 
active species in HO reaction (Figure 1-3).
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Figure 1-3. Reaction scheme of HO. 
a. In the first step, heme bound to HO is hydroxylated at the a-meso carbon, yielding 
a-hydroxyheme. In this reaction step, molecular oxygen bound to heme iron is activated 
to ferric hydrogen peroxide. The second step is the conversion of a-hydroxyheme to 
verdoheme IXa with the concomitant release of the a-meso carbon as CO. Lastly, the 
oxygen bridge of verdoheme IXa is cleaved, producing biliverdin IXa-iron chelate. 
Ferrous iron ion is smoothly released by the reduction of biliverdin IXa-iron chelate, 
then biliverdin IXa is released from HO. b. Schematic diagram of the proposed 
hydroxylation mechanism of heme, the first step of HO reaction. Around the a-meso 
carbon of heme is shown for clarity. The it electrons of porphyrin ring are directly 
donated to hydrogen peroxide bound to the heme iron, then the a-meso carbon of heme is 
hydrolylated. Thus it is required to achieve the regispecific reaction that the hydrogen 
peroxide bound to heme iron is directed to the a-meso carbon and the 1t electrons of 
porphyrin ring are localized at the double bond including the a-meso carbon.
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   Figure 1-4. Reaction mechanism proposed in cytochrome P450 and peroxidase 
    Second notable feature is the regiospecificity of the reaction. The regiospecificity of HO 
reaction would be physiollogically important because only bilirubin IXa, last product of 
HO-biliverdin reductase system, is hydrophobic although other isomers, bilirubin IXO, IXy, 
and IXB, are hydrophilic. Hydrophilic groups of bilirubin IXa form intramolecular 
hydrogen-bonds, thus these groups cannot be hydrated. Considering the proposed 
hydroxylation mechanism ofheme (Figure 1-3b), the regiospecific oxidation of heme would 
be achieved by two factors; the direction of 02 bound to heme iron and the localization of 
it-electron at the double bond including the a-meso carbon. The locallization of electron is 
suggested on the basis of the HO reactions of the chemically modified heroes (32,33) but the 
direction of the distal igand was unknown. 
    Third feature is the discrimination between 02 and CO. In general, CO is a competitive 
inhibititor of 02 binding to heme iron because CO strongly binds to the ferrous heme iron 
rather than 02 does. In case of Mb, the affinity of CO is 30-100 fold greater than that of 02 
affinity (34). 02 must bind to heme-HO where CO produced in HO reaction is locally 
concentrated. To overcome this dilemma, the affinity of 02 to heme-HO is increased and that 
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of CO is suppressed (35),however, this molecular mechanism was unknown.
Crystal structure of rat ferric heme-HO-1 
    In my master's course, I prepared rat ferric heme-HO-1 complex and determined its 
crystal structure (36). I summarize here the results as the background of this thesis. Rat HO-1 
consists of 289 amino acids and has a hydrophobic membrane-binding domain at the 
C-terminus. Recombinant rat HO-1, in which the C-terminal membrane-spanning region had 
been truncated, was expressed in E. coli JM109 and purified (figure 1-5, (37-39)). The 
truncated rat HO-1 shows an activity identical to that of native HO-1 using 
NADPH-cytochrome P450 reductase as sodium ascorbate for reductants. All HO described in 
this thesis is this truncated HO-l. Truncated HO-1 in complex with heme was crystallized in 
the condition that PEG 4000 was used for precipitant (38).
Figure 1-5. Expression and purification of rat HO-1.
Truncated rat HO-1 was expressed in E. coli JM109 and purified using ammonium sulfate 
fractionation and chromatography techniques using anion-exchange (Q sepharose HP, 
Amersham Biosciences, and POROS HQ, Applied Biosystems), hydroxyapatite (CHT typel, 
Bio-Rad Laboratories), and size-exclusion (Sephacryl S-200 HR, Amersham Biosciences) 
columns. Heme-HO complex was prepared by leaving the mixture solution of hemin and 
HO for one hour on ice and purified using hydroxyapatite column.
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    The determined sturucture has a novel folding, consisting of eight helices, A through H. 
The heme is sandwiched between the proximal helix, A (Leu-13-Glu-29), and distal kinked 
helix, F (Leu-129-Met-155) (Figure 1-6a) (36). Poulos et al. also determined the crystal 
structures of ferric heme-HO complexes of human (40) and Neisseria meningitidis (41) which 
are simlar to rat heme-HO structure. 
    The side-chain of His-25 in the A-helix serves as the proximal heme ligand, as predicted 
by spectroscopic and site-directed mutagenesis analyses (42,43). Proximal histidine in 
heme-HO is neutral as in Mb on the basis that the spectroscopic haracters of heme-HO is 
similar to that of Mb (28-31). Neutral histidine cannot donate electron strongly to the distal 
side of the heme. This is one of the differences between HO and cytochrome P450 or 
peroxidase; cysteine or acidic histidine, which can donate electron, serves as the proximal 
ligand (Figure 1-4). Before the crystal structure was determined, it was predicted based on the 
"push-pull" mechanism (Figure 1-4) that the dissociable residues as histidine are located in 
the distal side of heme and this residue catalyzes the activation of molecular oxygen bound to 
the heme iron. Contrary to this expectation, no dissociable residues are present in the distal 
side of the heme, but backbones of Gly-139 and Gly-143 in the F-helix are close to the distal 
ligand (Figure 1-6c). The distal F-helix, the amino acid sequence of this helix is highly 
conserved and named 'heme oxygenase signature' (44) (Figure 1-7), is flexible. In human 
ferric heme-HO-1 at neutral pH, two forms of this helix, "open" and "closed", are present (40). 
In rat ferric heme-HO-1 at alkaline pH, F-helix is more closed to heme than that of the closed 
form reported in human HO-1. 
    Heme is hydrophobically interacted with several residues, electrostatically interacted 
with Lys-18, Lys-179, and Arg-183, and hydrogen-bonded with Tyr-134 (Figure 1-6b,c). 
These interactions would determine the orientation of heme binding. Indeed, the R183D and 
R183E mutants altered the regiospecificity of HO reaction (45). 
    Although the crystal structures of these heme-HO complexes gave significant insights in 
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the enzymatic reaction, detailed reaction mechanism as well as characteristic features of HO 
reaction remained to be clarified. That is, how does HO incorporate substrates and release 
products? How does HO achieve the regiospecificity of the reaction? How is 0, incorporated 
in verdoheme in the presence of CO produced in the previous step? To answer these questions, 
I started the crystallographic studies of various reaction intermediates of HO, which include 
an unstable intermediate induced by the laser irradiation at cryogenic temperature. Aside from 
the crystallographic studies, I incorporated molecular dynamics simulation to see the 
migration of the produced CO in the hemepocket of HO and RR spectroscopy to characterize 
the novel ligand binding mode to the heme iron, with which the crystallographic results were 
substantiated.
9
Figure 1-6. Crystal structure of rat ferric heme-HO-1 complex 
a. Ribbon diagram of ferric heme-HO-1 complex. b. Electrostatic and hydrogen-bond 
interactions of heme propionates. Heme and water were colored green and yellow, 
respectively. Dashed lines indicate electrostatic and hydrogen-bond interactions of heme 
propionates and numerals indicate distances of interacted atoms. c. The structure of distal 
side of heme. Dashed lines indicates interactions of heme iron, its ligands, fixed water 
molecules in distal hemepocket, and HO residues. These figures were prepared with 
MOLSCRIPT (125) and RASTER3D (126).
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Figure 1-7. Amino acid sequence alignment of mammalian HO-1 and HO-2, 
Corynebacterium diphtheriae HO, and Neisseria meningitidis HO. Residues 
highlighted in black are the proximal ligand of heme and the conserved motif, "heme 
oxygenase signature" (consensus pattern; LXAHXYXXYXG), which is not conserved in 
N. meningitidis HO. Gray boxes, black lines, and broken lines indicate a-helices, loops, 
and disordered regions in rat heme-HO-1, respectively. Arrow indicates the 
trans-membrane r gion of mammalian HO.
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Chapter 1
Structural basis for the reaction mechanism of HO
INTRODUCTION 
    As described in the general introduction, notable features of HO reaction are classified 
into three categories; activation mechanism of 02 bound to the heme iron, regiospecificity of 
the reaction, and discrimination between 02 and CO. This chapter deals with the whole steps 
of HO reaction including substrate binding and product release. 
    In the first section, I discuss the substrate incorporation mechanism based on the 
structural comparison between apo and heme-HO. The incorporation of heme into apoproteins 
is indispensable for hemoproteins to acquire biological functions. Although most 
hemoproteins are unstable in the apo-state, such proteins as myoglobin (Mb), cytochrome b5 
(cyt b5), and cytochrome b562 (cyt b562) are partially unfolded, yet they have stable secondary 
and tertiary structures in their apo-state. In solution these apoproteins can be analyzed by 
various spectroscopic methods, therefore they are often used as models in studies of heme 
binding and of protein folding (46-48). HO is not a hemoprotein by nature, but once it binds 
heme, it behaves like a hemoprotein. The heme-HO complex activates molecular oxygen and 
accepts reducing equivalents from CPR as heme-containing monooxygenases. It also has 
spectroscopic features similar to those of Mb (28-31). As described in general introduction, 
ferric heme-HO primarily consists of a-helices as do many other hemoproteins. Furthermore, 
HO-1 (33 kD) is larger than sperm whale Mb (17 kD), rat microsomal cyt b5 (15 kD), and E. 
coli cyt b562 (14 kD). Clarification of the structure of apoHO should lead to an understanding 
of the structures of other hemoproteins. In particular, it should help clarify the structural 
changes caused by heme binding. 
    In the second section, I discuss the activation mechanism of 02 and the structural basis 
                           12
of the regiospecific hydroxylation based on the structure of N3--heme-HO, as an analog of 
hydrogen peroxide bound form. The HO reaction pathway consists of three sequential 
oxidation steps utilizing molecular oxygen and reducing equivalents from CPR (19,49). As 
shown in figure 1-3, the molecular oxygen coordinated to the ferrous heme iron is believed to 
direct its distal oxygen atom toward the a-meso carbon of the heme, and electrophilic addition 
of the protonated distal oxygen onto the a-meso carbon proceeds (17). Chemical studies using 
various peroxides as substrates of heme-HO show that the acitive oxygen species is not 
oxo-ferryl (Fe 4+=O), as in the cytochrome P450 reactions, but ferric-hydroperoxide (17,18). 
This scheme requires tereochemical onditions under which the molecular oxygen bound to 
heme iron is highly bent and directed toward the a-meso carbon of the heme. RR 
spectroscopic analysis has given an angle of nearly 110° for Fe2... 0-0 (50), but the direction 
of the 0-0 bond about he Fe 21.. 0 axis has not been determined. Azide is known to inhibit 
HO catalysis (2). On azide addition to ferric heme-HO, low-spin shift of the Soret band in the 
optical spectrum occurs (29,51), indicative that azide coordinates to the ferric heme iron. In 
the case of Mb, binding mode of azide is similar to that of molecular oxygen (52). It would be 
conceivable that N3--heme-HO is more suitable to a model of hydrogen peroxide bound 
heme-HO rather than that of 02 bound heme-HO because the redox state of heme iron of 
N3-heme-HO is same as that of hydrogen peroxide bound heme-HO. The direction of 
hydrogen peroxide bound to heme-HO is essential for understanding the regiospecific 
oxidation catalyzed by HO. I therefore determined the crystal structure of N3--heme-HO as a 
mimic of hydrogen peroxide bound form. 
    In the third section, I discussthe product release mechanism based on the structure of 
the biliverdin-iron chelate bound form (Figure 1-3a). Although major progress has recently 
been made in understanding the nature of the first hydroxylation of heme, the mechanisms for 
the subsequent s eps have been still unclear. The final step is known to require 02 and 
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reducing equivalents (17,53). It is believed that the reaction mechanism of the final step is 
similar to that of first hydroxylation step (Figure 1-3b) (54,55), but there is no direct evidence 
supporting the mechanism in the final step. Furthermore little is known about the mechanism 
whereby biliverdin is produced from verdoheme and finally released from the enzyme. For 
further investigation of the HO reaction mechanism, I determined the structure of the 
biliverdin-iron chelate bound form. In addition, when the crystals of the biliverdin-iron 
chelate bound form were prepared, HO reaction could be proceeded in the crystal by adding 
chemical reductant, indicating that HO keeps its activity even in the crystal.
14
1.1 Heme binding mechanism based on the structure of apoHO
ABSTRACT 
HO (apoHO) was crystallized as twinned P32 with three molecules in an asymmetric unit, and 
a its crystal structure determined at 2.55 A resolution. Structural comparison of apoHO and its 
complex with heme (ferric heme-HO) showed three distinct differences. First, the A-helix of 
the eight a-helices, A-H, in heme-HO, which includes the proximal ligand of heme (His-25), 
is invisible in apoHO. In addition, the B-helix, a portion of which builds the hemepocket, is 
shifted toward the heme pocket in apoHO. Second, Gln-38 is shifted toward the position 
where the a-meso carbon of heme is located in ferric heme-HO. Gln-38 Ns is 
hydrogen-bonded to the carbonyl group of Glu-29 located at the C-terminal side of the 
A-helix in ferric heme-HO, indicative that this hydrogen bond restrains the angle between the 
A- and B-helices in ferric heme-HO. Third, the amide group of Gly-143 in the F-helix is 
directed outward from the heme pocket in apoHO, whereas it is directed toward the distal 
ligand of heme in ferric heme-HO. This means that the F-helix around Gly- 143 must change 
its conformation to accommodate heme binding. The apoHO structure has the characteristic 
that the helix on one side of the heme pocket fluctuates, whereas the rest of the structure is 
similar to that of heme-HO, as observed in such hemoproteins as myoglobin and cytchromes 
b5 and b562. These structural features of apoHO suggest hat the orientation of the proximal 
helix and the position of His-25 are fixed upon heme binding.
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MATERIALS AND METHODS 
    Crystallizationof apoHO. Truncated rat HO-1 (Met-1-Pro-267) was expressed and 
purified as described in the general introduction (Figure 1-5, (37,38)). I screened the 
crystallization conditions of apoHO using Crystal Screen Kit (Hampton Research) with 
hanging-drop vapor-diffusion method at 277 K. The protein solution was mixed with an equal 
volume of each reservoir solution and equilibrated against each reservoir solution. Crystals of 
apoHO were obtained when a reservoir solution containing 2M ammonium sulfate, 2% PEG 
400, 5 mM strontium chloride, and 0.1 M HEPES-NaOH buffer (pH 8.0) was used. The 
protein concentration used for the crystallization was 20 mg ml-1 in 20 mM Tris-HCl buffer 
(pH 7.4) containing about 50 mM KCI. Rod-shaped crystals appeared after one day and grew 
to maximum size in five days (Figure 2-1).
Figure 2-1. ApoHO crystals. 
Scale bar indicates 100 gm 
length.
    Data Collection and Processing. For cryogenic data collection of the apoHO crystal, it 
was transferred to the artificial mother liquors, to which ethylene glycol was added to 12% 
(w/v). The crystal in the cryo-loop was cooled immediately with liquid nitrogen and mounted 
on the 90-degree Goniometer Head Arc (Hampton Research) with nitrogen gas stream at 100 
K. Diffraction data were collected at X = 0.709 A at 100 K by synchrotron radiation at the 
beamline BL41XU of SPring-8 equipped with a MarCCD detector. The distance between the 
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crystal and CCD was 222 mm. The crystal was oscillated 2.5 degrees per frame, and the total 
measurement angle was 150 degrees. The dataset was processed, merged, and scaled with 
MOSFLM (56) and SCALA in the CCP4 package (57,58). The crystallographic data and 
diffraction statistics are given in Table 1. DETWIN, in the CCP4 package (57,59), and CNS 
(60) were used to detect crystal twinning and to determine the twinning fraction. 
    Model building and Refinement. The apoHO structure was determined by the molecular 
replacement method with CNS (60). The cross-rotation and translation functions were 
calculated from the protein moiety of the rat ferric heme-HO structure (PDB code, 1DVE). 
The cross-rotation function gave the orientations of the three apoHO molecules present in an 
asymmetric unit. The subsequent translation function search gave the position of one of the 
three apoHO molecules in an asymmetric unit. The position of the second molecule was 
determined by the translation function fixing the position of the first molecule. After the 
positions of the two molecules were determined, the same process was used to establish the 
position of the third molecule. 
    The apoHO crystals obtained in this study were not single but hemihedrally twinned 
crystals. Britton plot analysis (61) and an analysis of the cumulative distribution of H (59) 
were used to determine the twinning fraction. Detwinned ata were used in all refinements, 
the twinning fraction being fixed at 0.45. Test reflections for calculation of the free R factor 
were selected as all the twin-related reflections belonged to the same sets (either the test or 
working sets) to avoid correlations introduced by twinning (59). Because the electron density 
corresponding to the A-helix in the ferric heme-HO structure was not clearly visible after 
simulated annealing refinement, he A-helices of the three molecules in the asymmetric unit 
were deleted from the model. Non-crystallography symmetry restraints were applied to the 
initial refinement then in subsequent refinements gradually relaxed. Non-crystallography 
symmetry restraints were not applied to the final refinement. A few cycles of water picking 
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and energy minimization refinements were performed. Temperature factors of all atoms were 
refined individually. All refinements were done using the reflections in the resolution range of 
50.0-2.55 A with CNS (60) and using the twinning option. Program 0 (62) was used to adjust 
and model the protein atoms and water molecules. Stereochemical hecks of all the models 
were made with PROCHECK (63). Refinement s atistics are given in Table 1. 
             Table 1 Summary of crystallographic statistics of apoHO
Crystallographic data 
  Space group 
 Unit cell dimensions (A) 
  No. of molecules in asymmetric unit 
  Twinning operator/fraction 
Diffraction statistics 
 Resolution (A) 
  No. of observations 
  No. of unique reflections 
  Completeness (%) 
  Mean I/6 
  tRsym 
Refinement s atistics 
  ttTwinned R/Rfree 
  tttDetwinned R/Rfree 
  No. of water molecules 
  Average temperature factors 
     molecule A (A) 
     moleculeB (A2) 
     molecule C (A2) 
  Rms deviations from ideality 
    bond lengths (A)
     angles (deg)
P32 
a=b=70.2, 
3 
k,h,-l / 0.45
c = 141.5
30.0-2.55 
93875 
25283 
99.9 (99.9)* 
9.9(2.9)* 
0.059 (0.250)*
0.202/0.307 
0.324/0.394 
85
35.1 
44.6 
38.7
0.009 
1.48
tRsym = Y-hk[ Y-i IIi(hkl) - <I(hkl)>I/ E hkl Ii Ii(hkl), <I(hkl)> is the mean intensity for multiple recorded 
reflections. 
ttTwinned R = EIFobs(hkl) - [Fcatc(hkl)2+Fcalc(kh-1)2]11211/ E IFobs(hkl)I. 
tttDetwinned R = E IFdetwi„ hkl - F is(hkl)II/ E IF                    ( ) ca d,,i,,(hkl)I. 
Each Rfree isthe R calculated for five percent of the dataset, not including refinements. * Values in parentheses are for the outermost hell (2.69-2.55 A). 
                          18
RESULTS 
    Determination of the space group and detection of twinning. Because the apparent 
diffraction pattern of the apoHO crystal had P3m1 Patterson symmetry (Rsym = 0.058) and 
(001) diffractions were absent when 1 # 3n, I firstly assigned the space group of the crystal as 
P3121 or P3221. When the space group of the crystal was assumed to P3221, two of the 
apoHO molecules in the asymmetric unit, determined by the molecular replacement method, 
severely interfered with each other. When the space group was assumed to be P32, the three 
molecules in the asymmetric unit were favorably packed. In this case, the R and Rfree factors in 
the refinements were not decreased (R/Rfree = 0.35/0.4), even though the model was well-fitted 
to the 2F, ,-F, map. The apparent space group of P3221 suggested that the crystal of the P32 
space group may be a perfect win, with a twinning operator of k,h,-l (64). To determine the 
twinning fraction, Britton plot analysis (61) and a plot of the cumulative distribution of H (59) 
were applied to the diffraction intensity data. Figure 2-2 shows that his crystal is a twin with 
a twinning fraction of 0.45.
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    Because it was a mimetic perfect winning crystal, I averaged the twin-related reflection 
intensities to simulate perfect winning and used this averaged ata for refinement on the 
assumption that the crystal had a perfect twinning (65). It should be noted that such 
refinement procedures were heavily biased toward a Fourier synthesis map from the model. I
therefore r fined the model with a twinning fraction of 0.45. 
    Overall structure. The apoHO structure has beenrefined to a twinned R factor of 0.202 
and a twinned free R factor of 0.307 at 2.55 A resolution. For statistical reasons, the 
difference between the R and Rfree factors in the presence of a twin can be higher than in the 
usual case (65,66). There were three molecules (A, B, and C) in the asymmetric unit. The 
final model had 4752 protein atoms and 85 water molecules. Approximately 30 N-terminal 
residues of the 267-residue protein, corresponding to the A-helix in ferric heme-HO, were 
deleted from the model because they were not ordered. The last 40 and several residues were 
also disordered, as seen in ferric heme-HO. The electron density of molecule B is 
discontinuous between residues 143 and 144. For molecule A residues 31-222, for B residues 
30-142 and 145-223, and for C residues 30-225 could be built. 
    Superposition of the structures of molecules A-C is shown in Figure 2-3. The three 
molecules have similar folds that mainly consist of (x-helices, as evidenced by the low value 
(0.67 A) of the overall rms deviation for Ca atoms. The plot of the rms deviations of the 
apo-forms (Figure 2-3c, solid line) shows that residues with a large deviation (> 1.5 A) are 
localized in the B-helix and B-C loop, and in the middle of the F-helix. A comparison of the 
overall structure of molecule A of apoHO with that of ferric heme-HO (Figure 2-3b) shows 
that the helices that form the heme pocket of ferric heme-HO (i.e., the A-, B-, and F-helices) 
fluctuate or are distorted in the apo-state, whereas the remainder of the apoprotein, including 
the C-, D-, E-, G-, and H-helices, has essentially the same folding as that of ferric heme-HO. 
When the rms deviations of the Ca atoms were calculated by combining the datasets for ferric 
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heme-HO and apoHOs (Figure 2-3c, dashed line), residues in the B-helix, B-C loop, and in 
the middle of the F helix had larger values than those calculated for apoHOs. In addition, 
deviation increased for the residues in F-2 (in this section, L120-D140 and G143-M155 are 
named F-1 and F-2 segments, respectively). The greatest part of the variance between the apo 
and holoproteins therefore is localized around the hemepocket. 
    Distal helix. An electron density map of molecule C around the hemepocket is shown in 
Figure 2-4a. In ferric heme-HO, the F-helix covers the distal surface of the heme, with closest 
access of Gly-139 and Gly-143 to a water or hydroxyl ligand (36). In contrast, the F-helix in 
apoHO, especially at the F-2 segment, shifts away from the heme pocket, although it remains 
bent (Figure 2-4b). The main-chain conformation of a few residues around Gly-143 changes 
from an a-helix to a random coil. The amide group of Gly-143 in molecule A is directed away 
from the heme pocket, whereas the carbonyl group of Gly-139 still points in the same 
direction as that in ferric heme-HO. The F-helix in molecule B fluctuates markedly, Gly- 143 
and Gly-144 being disordered. In molecule C, the F-helix adopts a conformation similar to 
that in molecule A, but the position of Gly-139 is altered in order for its carbonyl group to 
turn aside from the heme pocket.
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Figure 2-3. Comparisons of three molecules of rat apoHO and heme-HO. a. Stereo 
view of the Ca traces of molecules A (black), B (blue), and C (green) of rat apoHO in 
the asymmetric unit. Superposition was done to minimize the square deviations of the Ca 
atoms among all the amino acids. The N- and C-termini of the ordered segments 
respectively are shown as N and C. b. Stereo view of the Ca traces of molecule A of rat 
apoHO (black) and rat heme-HO (red). Superposition was done to minimize the square 
deviations of the Ca atoms among all the amino acids except the B- and F-helices. 
N-termini of the ordered segments of both molecules are shown in their respective colors 
as the letter N. c. Plot of the rms deviations of Ca atoms among apoHOs (solid line) and 
between apoHOs and heme-HO (dashed line). Solid horizontal bars indicate the helices 
in heme-HO. These figures were prepared with MOLSCRIPT (125) and RASTER3D 
(126).
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a.
Figure 2-4. Structural comparisons between apoHO and the HO-heme 
complex. a. 6A weighted 2F,,-F, map contoured at 1.3a (cyan) superimposed on 
the wire-frame model of molecule C of apoHO around the hemepocket. b. 
Superpositions of the models near the heme pocket of molecule A of apoHO 
(carbon; black, oxygen; red, nitrogen; blue) and rat HO-heme (green). Both 
molecules are shown as wire-frame models. Dashed lines indicate hydrogen bonds 
or coordinate bonds. These figures were prepared with MOLSCRIPT (125), 
CONSCRIPT (127), and RASTER3D (126).
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Figure 2-5. Structural changes in 
the hydrophobic and electrostatic 
interactions between HO and 
heme. Ribbon diagrams and wire 
frame models of heme and the side 
chains of Met-34, Phe-37, Lys-179, 
Arg-183, Phe-207, and Phe-214 of 
rat heme-HO (black) are shown. 
The side chains of molecule A 
(green), molecule B (red), and 
molecule C (blue) of apoHO are 
superimposed on heme-HO. This 
figure was prepared with 
MOLSCRIPT (125) and 
RASTER3D (126).
    Proximal side. In addition to the disorder of the A-helix in apoHO, the B-helix shifts 
toward the heme pocket, accompanied by several conformational changes in the side chains of 
its amino acid residues. For example, in ferric heme-HO, the Gln-38 NE is hydrogen-bonded 
to the carbonyl oxygen of the backbone of Glu-29 at a distance of 2.9 A, but in apoHO, the 
Gln-38 NE of molecule A is located near the position where the a-meso carbon of the heme 
originally was present in ferric heme-HO. The Gln-38s of the other molecules also shift 
toward the heme position. They are not near the a-meso carbon, rather they are closer 
(molecule C) to or occupy (molecule B) the position of the heme in ferric heme-HO (Figure 
2-4b). 
    In ferric heme-HO, Lys-179 and Arg-183 interact electrostatically with the propionate 
group of the heme (36,40). The Arg-183 of the three apoHO molecules and the Lys-179 of 
molecule C of apoHO have approximately the same conformations as those in ferric 
heme-HO (Figure 2-5), but the side chains of Lys-179 in molecules A and B are flipped at the 
Ca atom. As a result, Lys-179 NE more closely approaches the position at which the 
propionate group of the heme originally was present in ferric heme-HO (Figure 2-5). In ferric 
heme-HO, Met-34, Phe-37, and Phe-214 form a hydrophobic wall opposite the a-meso heme 
edge (36,40). These apoHO residues roughly retain their conformations, but Met-34 and
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Phe-37 approach the inside of the heme pocket due to the B-helix shift. In particular, the 
Phe-37 in molecule B is much closer to the position of the heme in ferric heme-HO than is the 
Phe-37 of the other apoHO molecules (Figure 2-5). The side chain of Phe-207, present under 
the a-meso edge of the heme (36,40), is flipped at the Ca atom and points down the position 
of the A-helix in ferric heme-HO (Figure 2-5). As a result, the fluctuations and distortions in 
apoHO lead to the exposure of the heme binding pocket to solvent. The hemepocket of
apoHO therefore should be more easily accessible for heme binding. 
    Core structure. The Ca atoms of residues 44-138 and 155-220 in apoHO can be 
superimposed onthe Ca atoms of the corresponding residues in ferric heme-HO with a low 
rms deviation of 0.55 A, indicating there is little change in the core structure of HO whether 
or not heme is present. An extended hydrophobic cluster is formed along the interfaces of the 
C-, E-, F-1-, and H-helices (Figure 2-6a). Aliphatic and aromatic residues of the two loops 
between the C- and D-helices and between the F-and G-helices also participate in this 
hydrophobic nteraction. The D- and G-helices exist outside of the core, but both establish van 
der Waals contacts with the C-helix and the first half of the F-helix, respectively, by forming 
hydrophobic nterfaces. In addition to these hydrophobic nteractions, both the helix-helix and 
helix-loop interfaces are stabilized by a number of hydrogen-bonded or electrostatic pairs: 
Tyr-58 and Asp-140, Glu-62 and Arg-86, Glu-66 and Tyr-78, Trp-96 and Gly-163, Arg-117 
and Glu-202, Arg-198 and Glu-127, Asn-210 and Arg-136, Glu-216 and Thr-108, and 
Glu-216 and Ala-110 (Figure 2-6b). 
    Like ferric heme-HO, the surface of the heme-binding side of apoHO is charged 
positively and the opposite one negatively (Figure 2-7). This feature is important for 
interaction with CPR. The surface charge distribution of apoHO is essentially the same as that 
of ferric heme-HO. CPR therefore would contact HO even in the apo state, but it remains to 
be explained how this interaction is involved in heme oxygenase catalysis. 
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Figure 2-6. Schematic representations of the core structure of apoHO. a. The 
hydrophobic ore of HO is shown. The C, E, F-1, and H helices are shown as cylinders. 
Hydrophobic residues (Leu, Ile, Val) in these helices are shown as ball-and-stick models. 
b. C-H helices in apoHO are shown as cylinders. Hydrogen bondings and electrostatic 
interactions conserved among the rat heme-HO and apoHOs are represented by dotted 
lines. Side chains involved in these interactions are shown as wire frame models. These 
figures were prepared with MOLSCRIPT (125) and RASTER3D (126).
Figure 2-7. Electrostatic potential of rat HO. Molecular surfaces colored by electrostatic 
potential were shown (blue: positive, red: negative). Left and right show the heme binding 
surface and its opposite, respectively. Heme binding surface is positively charged in apoHO 
and heme-HO. These figures were prepared with GRASP (128).
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DISCUSSION 
    The major differences in the crystal structures of ferric heme-HO and apoHO are 
limited to the helices directly involved in heme binding. The proximal helix, A, in apoHO is 
not visible in this analysis. The distal helix, F, partially fluctuates; its middle portion becomes 
a random coil and the latter half (Val-146-Ala-151) varies in conformation among the three 
apo forms. In contrast, both helices in ferric heme-HO are stabilized by a number of 
interactions with heme; i.e., coordination of the imidazole side chain of the proximal His-25 
to the heme iron, an electrostatic interaction between the N~H3+ group of Lys-18 and the 
propionate groups of the heme, and the hydrogen bonds between the backbones of the distal 
glycines and the distal water ligand of the heme. Other electrostatic interactions occur 
between the basic side chains of Lys-179 and Arg-183 and the propionate groups of heme. 
These electrostatic interactions present in rat HO-1 are also conserved in human HO-1 (40). 
Interestingly, the mutation of Arg-183 to Glu or Asp was found to cause changes in the 
a-regioselectivity of the heme oxygenase reaction (45). It is noteworthy that the basic side 
chains of Lys-179 and Arg-183 in apoHO maintain an orientation similar to those in the 
holo-state. Furthermore, in the holoprotein, a hydrogen bond between the backbone of Glu-29 
in the A-helix and the side chain of Gln-38 in the B-helix appears to contribute to the 
formation of the heme pocket. A previous study showed that replacement of the proximal 
His-25 with Ala led to the loss of HO activity, but this substitution did not significantly affect 
the molecule's heme-binding capability, indicative that these stated additional interactions, 
rather than the coordination of His-25 to heme, are crucial in the initial stage of heme binding 
(43). 
    When all these findings are considered, they suggest a possible induced-fit model for 
the binding of heme to HO (Figure 2-8). Before heme binding, the A-helix assumes a random 
conformation such that the heme pocket is exposed to the solvent. The side chain of Gln-38 
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partially occupies the binding site. Once heme binds to the heme pocket, Gln-38 and the 
B-helix shift away from the pocket to avoid steric hindrance between the heme and Gin-38. 
The electrostatic interaction between the propionate groups of heme and the side chains of 
Lys-179 and Arg-183 would facilitate the correct orientation of the heme. Gln-38 Ns then 
forms a hydrogen bond to Glu-29 0 of the A-helix, and the angle between the A- and 
B-helices is fixed. Finally, Lys-18 and the propionate groups of the heme form a salt bridge, 
and His-25 Ne ligates to the heme iron. The structural features of the heme pocket are well 
conserved in rat and human HO-1s, suggesting that mammalian enzymes use a similar 
mechanism to incorporate the heme substrate. 
                                   Lys-179 Lys-179 
      Lys-179               Gln-3'(/ Gln-38 -: Gin-38                                 Arg-183 G Arg-183 _ ;_ 
Arg-183 His-25                                                              k Lys-18 G =~
          Figure 2-8. The proposed mechanism of heme binding to apoHO. 
    Recentrly, the crystal structure of the Neisseria meningitides HO in complex with them 
was determined (41). Gln-38 is conserved among mammalian HO-1s, but is substituted for 
Val in N. meningitidis HO. This substitution suggests that the binding mechanism of the heme 
of N. meningitidis HO may differ somewhat from that in our proposed model (Figure 2-8). In 
N. meningitidis heme-HO, there is a C-terminal loop at the position where the B-helix is in 
ferric heme HO. The A-helix should be stabilized by the interaction between the A-helix and 
the C-terminal loop via hydrogen bonding (Asp-28 NS - Met-208 0) in N. meningitidis 
heme-HO. In mammalian HO-1 s, the segment which corresponds to the C-terminal loop in 
the N. meningitidis heme-HO is disordered, but its structure probably differs from that of the 
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N. meningitidis heme-HO because there is no sequence similarity between the mammalian 
HO-1 and N. meningitidis HO in this region (Figure 1-7). Mammalian HO-ls are 
membrane-bound proteins that span the membrane of the endoplasmic reticulum at the 
C-terminus, and N. meningitidis HO is a soluble protein (67). This difference is thought o be 
responsible for the structural difference at the C-termini. 
    The kinking and flexibility of the distalhelix are believed to be crucial factors for heme 
oxygenase catalysis. An asymmetric unit of human ferric heme-HO crystals has "closed" and 
"open" forms
, which differ in the distance between the distal helix and heme plane (40). The 
opening of the active site has been inferred to allow substrate binding and product release, 
while the closing of this site would enforce regioselectivity and facilitate the reaction. In 
apoHO, the three molecules in the asymmetric unit have different conformations in the 
segment hat corresponds to the F-2 segment in ferric heme-HO. Moreover, a few residues 
around Gly-143 have changed their secondary structures to a random coil, indicative that thiss 
segment forms an unstable conformation in apoHO. The flexibility of this segment differs 
from that at the kinked site (Leu-141-Ser-142), causing an overall shift of the F-2 segment as 
seen in the structures of heme-HOs (36,40,41). The primary factor that determines the 
flexibility in apoHO probably is the absence of heme because this segment has direct contact 
with the heme plane, and the distal ligand of the heme iron is hydrogen-bonded to the 
Gly-143 in rat heme-HO (36). Unlike the proximal and distal helices, the remainder of HO 
retains its structure, irrespective of whether or not heme is bound. Five helices (C, D, E, G, 
and H) and part of the F-helix assemble to form the extended hydrophobic core. This core 
structure most likely provides stability for the overall structure of the enzyme thereby 
minimizing conformational change both on the binding of the substrate and release of the 
product. 
    It should be noted that, consistent with the structure of apoHO, the known structures of 
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the apoproteins cyt b5 (68,69) and cyt b562 (70) have a similar feature in common; one of the 
axial helices fluctuates greatly, whereas the other emains folded. Studies of several of apoMb 
properties have indicated that apoMb is in the molten-globule- state (71) and that one side of 
its heme pocket (F-helix) is disordered (72). Although HO, Mb, cyt b5, and cyt b562 show a 
similar structural changes around the heme pocket upon heme binding, there is no similarity 
in their overall structures; HO (36,40,41), Mb (73), cyt b562 (74) are all a proteins with 
different folding motifs and cyt b5 (75) consists mainly of anti-parallel 1 sheets and a helices. 
This finding suggests hat there is a common feature between the pathways to maturation of
the three b-type hemoproteins and the heme binding in heme-HO is inserted into the opened 
heme pocket of the apoprotein, fixes the orientation of the disordered helix, and stabilizes the 
conformation ofthe heme pocket. 
    Poulos et al. haverecently determined human apoHO-1 structure (76). F-helix 
conformation and the disruption of hydrogen bond between Gln-38 and Glu-29 are similar to 
our result, but A-helix in their structure is ordered. This difference may be caused by the 
difference of crystal packing; A-helix in their crystal was interacted with other apoHO 
molecules, but estimated A-helix regions in our crystal were free from the interaction of other 
apoHO molecules.
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1.2 Hydroxylation mechanism of heme based on the structure of ferric heme-HO 
bound to azide 
ABSTRACT 
Heme oxygenase (HO) catalyzes physiological heme degradation consisting of three 
sequential oxidation steps that use molecular oxygen and reducing equivalents. I determined 
the crystal structure of rat ferric heme-HO-1 complex bound to azide at 1.9 A resolution. The 
azide bound to heme iron are directed toward the a-meso position of the heme. Azide shows 
bent-binding mode as well as the binding mode of molecular oxygen based on RR 
spectroscopic analysis using isotope shift. The azide is surrounded by residues of the distal 
F-helix, only the direction to the a-meso carbon being open. This indicates that regiospecific 
oxidation of the heme is primarily caused by steric constraint between the molecular oxygen 
bound to heme and the F-helix. The azide interacts with Asp-140, Arg-136, and Thr-135 
through a hydrogen bond network involving five water molecules on the distal side of the 
heme. This network, also present in ferric heme-HO, may function in molecular oxygen 
activation in the first hydroxylation step. From the orientation of azide in its bound form, 
hydrogen peroxide, the active oxygen species of the first reaction, bound to ferric heme-HO is 
inferred to have a similar orientation suitable for direct attack on the a-meso carbon
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MATERIALS AND METHODS 
    Crystallizationof N3--heme-HO. Ferric heme-HO was prepared as described in the 
general introduction (Figure 1-5, (37-39)). N3--heme-HO was prepared by adding sodium 
azide to ferric heme-HO at the final concentration of 5 mM. The crystallization condition of 
N3--heme-HO was screened with Crystal Screen (Hampton Research) by the hanging-drop 
vapor-diffusion method. The protein solution was mixed with an equal volume of each 
reservoir solution and equilibrated. Crystals of N3--heme-HO were obtained at 293 K when 
the reservoir solution contained 4 M sodium formate. The protein concentration for 
crystallization was 18 mg ml-1 in 50 mM potassium phosphate buffer (pH 7.0) containing 5 
mM sodium azide. Hexagonal rod-shaped crystals appeared after three days and grew to 
maximum size in a few weeks (Figure 3-1). 
                                              Figure3-1. Crystals of 
                                                N3 -heme-HO 
    Data Collection and Processing. The N3--heme-HO crystal soaked for a few seconds 
in a crystallization solution containing 50 mM sodium azide immediately changed to bright 
red. The crystal was then handled with a cryo-loop and flash-cooled with a nitrogen gas 
stream at 100 K. Diffraction data were collected at 100 K using synchrotron radiation (2 _ 
1.000 A) at the beamline BL40B2 of SPring-8 and an ADSC Quantum4R detector. Diffraction 
data were processed, merged, and scaled with HKL2000 (77). Crystallographic data and 
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diffraction statistics are given in Table 2. 
    Model building and Refinement.The structure of N3--heme-HO was determined by the 
molecular replacement method with CNS (60), in which the protein moiety of the rat 
heme-HO-1 complex (PDB code, 1DVE) was the search model. Cross-rotation function gave 
a unique solution. A subsequent ranslation search with the above solution located the 
N3--heme-HO molecule in an asymmetric unit. Rigid body, simulated annealing, and 
temperature-factor refinements were applied to the solution based on 20.0-2.5 A resolution 
data. The structure was revised by alternately adjusting the model with XtalView (78) and 
simulated annealing and temperature-factor refinements for 20.0-2.2 A resolution data. The 
heme was clearly seen in the electron density map and was included in the subsequent 
refinement. A few cycles of water picking and energy minimization refinements were done on 
the 20.0-1.9 A resolution data. Two azide ions were located in the FO-Fc map; one is bound to 
the ferric heme iron, the other to Arg-27 located on the molecular surface. Lastly, they were 
included in the energy minimization refinement, in which the geometry of the azide ions was 
restrained but neither the Fe3+.. NN angle nor Fe3.. N distance was restrained. All 
refinements were done with CNS (60). The stereochemical heck of the model was made with 
PROCHECK (63). Refinement s atistics are given in Table 2. 
    ESR measurement of N3 -heme-HO. The concentration f the ferric heme-HO complex 
was 600 uM in 50 mM potassium phosphate buffer (pH 7.0) containing 6mM sodium azide. 
X-band ESR spectra were recorded at 13 K using a JEOL ESR spectrometer (JES FE3X) 
equipped with a JEOL liquid helium cryostat (ES-LTR5X). The instrumental conditions were: 
modulation frequency, 100 kHz; modulation amplitude, 2 mT; microwave frequency, 8.93 
GHz; and microwave power, 1 mW. The microwave frequency was calibrated with a 
microwave frequency counter (Advantest) and the magnetic field strength determined with a 
JEOL NMR counter (JEOL ES-OC 1). 
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Table 2 Summary of crystallographic statistics of N3 -heme-HO
Crystallographic data 
   Crystal system 
   Space group 
   Unit cell dimensions (A) 
   No. of molecules in an asymmetric unit 
Diffraction statistics 
   Resolution (A) 
    No. of observations 
   No. of unique reflections 
   Redundancy 
   Completeness (%)*
   Mean Ida 
    Rsym
Refinement statistics 
   R/Rfreett 
   No. fprotein/heme atoms 
   No. of inhibitors/water molecules 
   Rms deviation from ideality 
       bond lengths(A)
       Angles (deg)
   Ramachandran plots 
        Most favored (%) 
       Additionallyallowed (%)
Trigonal 
P3221 
a = b = 65.0, c = 120.3 
1
20-1.9 
169,506 
23,376 
7.25 
97.9 (96.1) 
11.6 
0.054 (0.325)
0.189/0.219 
1718/43 
2/186
0.005 
1.09
93.7 
6.3
t Rsym = Y-hkl Y-,11;(hkl) - <I(hkl)>I/ E hkl E, I;(hkl), <I(hkl)> is the mean intensity 
for multiple recorded reflections. 
tt R = EIFobs(hkl) - Fcaic(hkl)II/E Fobs(hkl)I. 
Rfree is the R value calculated for five percent of the dataset not included 
refinements. * V
alues in parentheses are for the outermost hell (1.93-1.90A).
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RESULTS 
     Overall structure. The structure of N3--heme-HO was refined by use of the 1.9 A 
resolution data to an R/Rfree of 0.189/0.219. Ser-10 and Glu-223 are additionally disordered as 
compared with ferric heme-HO. The structure of N3--heme-HO consists mainly of a-helices 
and is very similar to that of ferric heme-HO (Figure 3-2), overall rms deviation for Ca atoms 
being 0.32 A. Deviation of the heme iron in N3--heme-HO and ferric heme-HO is 0.21 A. 
Although parts of the F-G (Ala-156-Glu-162) and G-H (Glu-190-Val-195) loops differ in the 
conformations between N3--heme-HO and ferric heme-HO, the differences should be due to 
the crystal packing force because these loops are located on the molecular surface and are in 
contact with other molecules in the crystal. The A-, B-, and F-helices, which form the heme 
pocket of N3--heme-HO, have the same conformations as in ferric heme-HO, and this heme 
also does not change position on azide binding.
 Figure 3-2. Structural comparison of heme-HO and N3 -heme-HO. Stereo diagram of 
 Ca traces; heme-HO (black), N3--heme-HO (green). Models are superimposed to minimize 
 rms deviations of the Cas of all the amino acid residues. Alphabets represent helices in 
heme-HO. These figures were prepared with MOLSCRIPT (125) and RASTER3D (126). 
    Heme orientation. The structure of N3--heme-HO was analyzed at a higher resolution 
than that of the structure of rat heme-HO (36), permitting a more detailed description of the 
manner of heme binding to HO-1. Close examination of the heme's electron density indicated 
that it binds to rat HO-1 in two different orientations, which are related by 180° rotation about 
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the (x-,y axis of the heme, which agrees with an NMR report (79). In addition, residual electron 
density was present near one of the two propionate groups, exposed to the solvent, indicative 
of double conformers. Double conformers for one propionate group in heme have been 
reported in N. meningitidis heme-HO (41). The two orientations of the heme and two 
conformations of the propionate group would not affect he regiospecificity of HO catalysis 
because the a-meso carbons in both orientations are at the same position. The present 
refinement includes only the major orientation of the heme and conformation of the 
propionate group, because it is still difficult at the present resolution to determine the ratios of 
the two alternative orientations and conformers. 
     N3--heme-HO heme pocket. An electron density map around the heme pocket of 
N3--heme-HO is given in Figure 3-3a. The F,, Fc map shows elongated ensity on the distal 
side of the heme, assignable to the azide coordinated to the ferric heme iron. The distance 
between the azide and iron is 2.2 A. The azide is nearly parallel to the heme plane 
(ZFe3+-N(3)-N(1) angle = 116°) and directed toward the a-meso carbon of the heme. 
Residues in the heme pocket of N3--heme-HO are positioned very similarly to those of 
heme-HO, in which a hydroxide is bound to the ferric heme iron. The N(3) atom of the azide 
is in a van der Waals interaction with Gly- 139 0 (2.7 A) and is hydrogen-bonded to Gly- 143 
N (2.8 A), as in the hydroxide coordinated to the heme-HO iron. In addition, the terminal 
nitrogen atom, N(1), is in contact with Gly-144 N (3.1 A). It should be noted that the five 
water molecules involved in the hydrogen-bonding etwork at the distal pocket of 
N3--heme-HO are located in almost identical positions as those in heme-HO, rms deviation 
being less than 0.6 A. Azide interacts with the carboxyl group of Asp-140 via W1 and W2 
and with the carbonyl groups of Thr- 135 and Arg- 136 via W1 and W3 (Figure 3-3b).
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Figure 3-3. Structure of N3 -heme-HO around the heme pocket. a. Stereo diagram 
showing 6A weighted 2Fo F, map contoured at 1.56 (cyan) superimposed on the heme 
pocket of the wire-frame model of N3 heme-HO. Red shows a 6A weighted FO-F, map 
contoured at 3.56, calculated by omitting the azide and five water molecules. b. Stereo 
diagram showing the hydrogen bond network on the heme's distal side in N3--heme-HO. 
Dashed lines indicate both hydrogen and coordinate bonds. Distances hown are in 
angstrom units. The Fe3+ • •N -N angle is in degrees. Water molecules involved in the 
hydrogen bond network are labeled W 1-W5. Distances are azide N(l) • • Wl; 2.7 A, 
W I • W2; 2.6 A, W 2 • • Asp-140 0; 3.0 A, Asp-140 OS.- Tyr-5 8 Orl ; 3.0 A, Asp- 140 
08 • Arg-136NIl;3.0A,W3••Thr-1350;3.0A,W3••Arg-1360;2.8A,WI..W3;2.8A, 
W I W4; 2.8 A, and W2 • • W5; 2.7 A. These figures were prepared with MOLSCRIPT 
(125), CONSCRIPT (127), and RASTER3D (126).
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     The detailed structure of the protein part of N3--heme-HO around its heme pocket is 
identical to that of ferric heme-HO (pH 8.5) in spite of their having different crystal packings 
and crystallization pHs. I reported that there is a structural difference around the heme pocket 
in rat and human (pH 7.5) heme-HO complexes, because spectroscopic studies of heme-HO 
show a pH-dependent transition of the spin state of the heme iron (pKa 7.6) (28). I concluded 
that this structural difference reflects the spin state of the heme iron (36). Spectroscopic 
studies of N3--heme-HO at pH 7.0 and heme-HO at pH 8.5 show that both of their heme irons 
are in the low-spin state (51). Rat N3--heme-HO gave a typical low-spin ESR signal with g 
values of 2.89, 2.21, and 1.67 at 10K, which puts it within the H-family (the sixth ligand is an 
anionic N atom) as categorized by Blumberg and Peisach (80). These agrees with the likeness 
in structural identity of heme-HO and N3--heme-HO, and is consistent with our previous 
findings on the structural difference between the rat and human heme-HO complexes.
DISCUSSION 
    The structure of N3--heme-HO shows that azide binds to the ferric heme iron in a bent 
form. The bending angle is 116°, consistent with previous RR analysis finding for an 
oxy-form of the heme-HO complex, showing a highly bent structure for the coordinated 
molecular oxygen of -110° (50). Although the direction of the molecular oxygen has not been 
determined, the present crystal structure provides the first evidence that a heme ligand is 
actually directed toward the a-meso carbon of the heme bound to HO. Both the highly bent 
coordination and the a-meso orientation of the heme ligand are required for the first 
hydroxylation step of the HO reaction, because chemical studies of heme analogs in a 
complex with HO suggest hat the active oxygen species, hydroperoxide, directly attacks the 
a-meso carbon of heme in the first step (Figure 1-3b, (17,18)). The N3 bound structure 
therefore should provide a suitable model for studying the regiospecifity of the HO reaction. 
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Several interactions between the azide and heme-HO are involved in determining the 
direction of both ligands about the Fe-ligand axis. The major interactions are van der Waals 
interactions with Gly-139 and Ser-142 and hydrogen bond interaction with Gly-143 N. CPK 
modeling of the residues surrounding the azide and heme (Figure 3-4) does in fact show that 
the azide is forced to direct its terminal nitrogen, N(1), toward the a-meso carbon.
Figure 3-4. Interaction 
between HO and azide. CPK 
model showing G1 y- 139, 
Ser-142, Gly-143, Gly-144, 
heme, and the azide. Carbons, 
nitrogens, and oxygens of 
heme and protein, 
respectively, are shown in 
gray, blue, and red. Azide 
atoms are shown in orange. 
The figure was prepared with 
MOLSCRIPT (125) and 
RASTER3D (126).
    Another important finding is that the hydrogen-bonding network at the distal pocket in 
heme-HO is highly conserved even in the azide-binding states. Similar hydrophilic 
interactions occur at the distal pockets in heme complexes with human HO-1 (40) and N. 
meningitidis HO (41), in which water or a hydroxy ligand exists. The hydrogen-bonding 
network reported here should help stabilize accommodation of the distal ligand, a hydrogen 
bond acceptor, located 2.7 A from W 1 (Figure 3-3). The explanation of hydrogen-bonding 
interactions is shown schematically in Figure 3-5. The carboxylate group of Asp-140, forms a 
salt bridge to the side chain of Arg-136 and interacts with the hydroxy group of Tyr-58, 
making W 1 anionic through a hydrogen-bonding relay intermediated by W2. In addition, the 
hydrogen-donating ability of W1 is enhanced by the carbonyl groups of Thr-135 and Arg-136 
via W3. W 1 therefore is a potent hydrogen donor to the coordinated azide, and the terminal 
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nitrogen atom, N(1), becomes positively charged. Moreover, the positive charge on N(1) is 
increased by the negative charge of the iron-bound nitrogen atom, N(3), which is 
hydrogen-bonded to the amide group of Gly-143. Taking this molecular polarization into 
account, an asymmetric resonance structure is dominant for the azide bound to heme-HO, as 
previously proposed for the Mb bound to azide (52). Tyr-58, Arg-136, and Asp-140 are all 
conserved in mammalian HO-1 and HO-2, indicative of their importance in the 
hydrogen-bonding network. 
       Cf Y58 
O H 
              ~O NH2         ^O O,         D1 40 CN 
                            0 ; -----H2N NH 
H 
            )OW2 
   G143 8 _ ,H R1 36 
-N
. 
_ 6+_H 'O"-H` O~H' NH     H• .N~iW1 
        N ,-N~~ •• W3 H---O 
                               T135 
  -Fe 3+-
      N Figure 3-5. Schematic view of hydrogen-bonding interactions        \> around the azide bound tothe ferric heme iron. 
N 
 H25 H 
    Conceivably, the hydrogen-bonding network facilitates formation of ferric hydrogen 
peroxide by providing a proton to the peroxide produced by reduction of the molecular 
oxygen bound to the ferrous heme iron in the first HO reaction step. Like the azide, hydrogen 
peroxide is probably directed toward the a-meso carbon in a way that minimizes van der 
Waals repulsion with the distal residues. Although peroxide is shorter than azide, 
hydrogen-bonding between the peroxide and W 1 should occur by minimal rearrangement of 
the bridging water molecules. Indeed, the distance between W 1 and the hydroxy ligand in 
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 Figure 3-6. A possible mechanism of protonation and activation of the peroxide 
 bound to heme. Open arrows represent the hydrogen-bonding etwork that enhances 
 the hydrogen-donating ability of W 1. 
heme-HO is 4.0 A (36) and the 0-0 distance of hydrogen peroxide is estimated as 1.46 A. 
Accordingly, the distal oxygen of hydrogen peroxide acquires apositive charge through the 
hydrogen-bonding etwork, as well as through the amide group of Gly-143, resulting in 
stabilization of the negatively charged proximal oxygen. Increased electrophilicity of the 
distal oxygen should be favorable for oxidation of the a-meso carbon of the heme. Recent 
findings of site-directed mutagenesis analysis of the polar residues around the distal pocket of 
heme-HO show that he D140A mutant completely ost heme degradation activity (81,82) and 
that in the R136A mutant heme degradation was much slower than in the wild type HO (82). 
An ESR and ENDOR study by Davydov et al. showed that one-electron radiolytic 
cryoreduction of the oxy-ferrous form of the heme-HO complex at 77 K yields a 
hydroperoxoferri-HO species, evidence of prompt proton transfer from the distal 
hydrogen-bonding etwork to reduced molecular oxygen (83). More recently, they reported 
that the annealing of this species to 200 K resulted in formation of an active hydroperoxo 
intermediate with a second well-defined 1H ENDOR signal (84). This intermediate directly 
formed an a-hydroxyheme product. They speculated that he second proton might have been 
part of a hydrogen bond that functions in the activation of the 0-0 bond for cleavage. It is 
noteworthy that the second proton detected in the ENDOR spectroscopy may be the amide 
proton of Gly-143, and it is expected to interact with the proximal oxygen of the hydrogen 
peroxide based on the hydroxide-bound heme-HO (36) and current N3--heme-HO structures. 
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Based on these findings, a possible mechanism of protonation 
bound to heme is proposed (Figure 3-6).
and activation of the peroxide
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1.3 Products release mechanism based on the structure of HO in complex with 
biliverdin IXa-iron chelate 
ABSTRACT 
The crystal structure of rat HO-1 in complex with biliverdin-iron chelate 
(biliverdin(Fe)-HO-1), the immediate precursor of the final product, biliverdin, has been 
determined at2.4 A resolution. The electron density in the heme pocket clearly showed that 
the tetrapyrrole ring of heme is cleaved at the a-meso edge. Like the heme bound to HO, 
biliverdin-iron chelate is located between the distal and proximal helices, but its 
accommodation state appears to be less stable in light of the disordering of the 
solvent-exposed propionate and vinyl groups. The middle of the distal helix is shifted away 
from the center of the active site in biliverdin(Fe)-HO-1, increasing the size of the heme 
pocket. The hydrogen-bonding i teraction between Glu-29 and Gln-38, considered torestrain 
the orientation of the proximal helix in the heme-HO-1 complex, was lost in 
biliverdin(Fe)-HO-1, leading to relaxation of the helix. Biliverdin has a distorted helical 
conformation with the lactam oxygen atom of its pyrrole ring-A interacting with Asp-140 
through ahydrogen-bonding solvent network. Owing to the absence of a distal water ligand, 
the iron atom is five-coordinated with His-25 and four pyrrole nitrogen atoms. The 
coordination geometry deviates considerably from a square-pyramid, suggesting that the iron 
may be readily dissociated. I speculate that the opened conformation of the heme pocket 
facilitates equential product release, first iron then biliverdin, and that owing to biliverdin's 
increased flexibility iron release triggers its slow dissociation.
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MATERIALS AND METHODS 
    Preparation of the biliverdin(Fe)-HO-1 crystal. Biliverdin(Fe)-HO-1 crystals were 
prepared by soaking CN--heme-HO-1 crystals, which were prepared as shown in the section 
2.1, in a solution of 4 M sodium formate and 50 mM potassium phosphate (pH 7.4), with 100 
mM sodium ascorbate as the reducing agent, until the crystal color changed to green (about 3 
hours) (Figure 4-1). A small crystal (50 tm wide) was used for the data collection because 
large crystals (more than 100 µm wide) were apt to crack or dissolve during preparation.
Figure 4-1. HO 
reaction in crystal
    Data Collection and Processing. The biliverdin(Fe)-HO-1 crystal was held in a 
cryo-loop and flash-cooled in a nitrogen gas stream at 100 K. Diffraction data were collected 
at 100 K using synchrotron radiation (X = 1.000 A) at the beamline BL41XU of SPring-8 and 
a MarCCD system. The crystal to CCD distance was 130 mm. The crystal was oscillated 1.5° 
with an exposure time of 40 s per frame, the total measurement angle being 120°. Diffraction 
data were processed, merged, and scaled with MOSFLM (56) and SCALA (57,58). 
Crystallographic data and diffraction statistics are given in Table 3. 
    Model building and Refinement. Because the biliverdin(Fe)-HO-1 crystal was 
isomorphous with the CN--heme-HO-1 crystal, the structure of biliverdin(Fe)-HO-1 was 
determined using the structure of the protein moiety of CN--heme-HO-1 (39). Rigid-body, 
simulated annealing, and temperature-factor refinements were applied to the model using the 
50.0 - 2.4 A resolution data. XtalView (78) was used to revise the structure. In this step, the 
cleaved tetrapyrrole ring was clearly visible in the electron density map. After one cycle of 
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water picking and energy minimization refinement, an additional electron density appeared 
around the N-terminal residue (Gln-11), to which the model from Ser-7 to Ser-10 was fitted. 
After one cycle of water picking, energy minimization, and temperature-factor refinements, 
the model of biliverdin(Fe) moiety was fitted to the 6A weighted F,,-F, map in the hemepocket. 
Lastly, energy minimization and temperature-factor refinements were applied to the model, 
including biliverdin(Fe). Neither the torsion angles of the tetrapyrrole rings in the 
biliverdin(Fe) moiety nor the coordination bonds to the heme iron were restrained in the 
refinements. All refinements were done with CNS (60). The stereo-chemical check of the 
model was carried out with PROCHECK (57,63). Refinement statistics are given in Table 3.
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Table 3 Summary of crystallographic statistics of biliverdin(Fe)-HO
Crystallographic data 
  Crystal system 
  Space group 
 Unit cell dimensions (A) 
  No. of molecules in an asymmetric unit 
Diffraction statistics 
  Resolution range (A) 
  No. of observations 
  No. of unique reflections 
  Redundancy 
  Completeness (%)* 
  Mean 10/6 
  Rsymt' 
Refinement statistics 
  R/Rfreett 
  No. of protein/biliverdin(Fe) atoms 
  No. of water molecules 
  Rms deviations from ideality 
     bond lengths (A) 
     angles (deg)
  Ramachandran plot 
      Most favored (%) 
     Additionallyallowed (%)
Trigonal 
P3221 
a = b = 65.4, c= 
I
50-2.4 
88285 
12207 
7.2 
99.7 (99.7) 
7.1 (2.2) 
0.090 (0.343)
0.194/0.239 
1729/40 
74
0.006 
1.14
92.7 
7.3
121.3
t Rsym = Ebk,E;11;(hkl) - <I(hkl)>l / EnkIE;I;(hkl), <I(hkl)> is the mean intensity 
for multiple recorded reflections. 
 tt R = EIFobs(hkl) FeaIc              ,(hkl) / EIFobs(hkl)I. 
Each Rfree isthe R value calculated for ten percent of the dataset not included 
 in the refinement.  * V
alues in parentheses are for the outermost hell (2.53-2.40A).
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RESULTS 
    Protein Structure. The structure of biliverdin(Fe)-HO-1 was refined using 2.4 A 
resolution data to the R factor of 0.194 and the free R factor of 0.239. Six residues at the 
N-terminus and 46 residues at the C-terminus are disordered in the biliverdin(Fe)-HO-1 
crystal. Main-chain atoms from Ser-7 to Met-9 were ordered as compared to heme-HO-1, but 
the side-chain of Met-9 was disordered. The structure of biliverdin(Fe)-HO-1 consists of eight 
helices, A through H, and is similar to that of heme-HO-1 (Figure 1-6), the root mean square 
deviation for Ca atoms being 0.26 A. The biliverdin(Fe) is wedged between A- and F-helices 
at a position corresponding to the heme in heme-HO-1. The plot of the deviations of Ca 
atoms between biliverdin(Fe)-HO-1 and heme-HO-1 (Figure 4-2, solid line) shows that 
residues with a large deviation (> 0.8 A) are localized in the middle of the F-helix and in the 
FG and GH loops. These two loops are located on the molecular surface and can easily adopt 
different conformations depending on the crystal packing force. Indeed, the structures of 
heme-HO-1 and N3--heme-HO-1, although determined from different space groups, differ in 
the conformation of these two loops, but the rest of their structures are similar. In particular, 
the heme pocket structure and positions of the water molecules involved in the distal 
hydrogen-bonding etwork, considered essential for catalysis (81,82), are well conserved as 
shown in the section 1.2. The plot of the deviations for the Ca atoms between 
biliverdin(Fe)-HO-1 and N3--heme-HO-1 (Figure 4-2, dashed line) (both isomorphous 
crystals) shows a large deviation only in the middle of the F-helix. Therefore, essential 
structural differences between the substrate (heme)- and product (biliverdin(Fe))-bound forms 
are chiefly restricted to the middle of the F-helix.
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Figure 4-2. Plots of the deviations of Ca atoms between biliverdin(Fe)-HO-1 and 
heme-HO-1 (solid line) and between biliverdin(Fe)-HO-1 and N3 -heme-HO-1 
(dashed line). Solid horizontal bars represent the helices in heme-HO- 1.
Figure 4-3. Comparison of the hemepocket structures of biliverdin(Fe)-HO and 
N3 -heme-HO-1. Ball and stick models of the hemepockets of biliverdin(Fe)-HO (left) 
and N3--heme-HO (right). For clarity, in the F-helix only main-chain atoms are shown. 
Dashed lines indicate hydrogen bonds that stabilize the two conformers. Numerals show 
distances between atoms in angstrom units. This figure was prepared with MOLSCRIPT 
(125) and RASTER3D (126).
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Table 4 Selected distances (A) of atoms at the distal heme pocket.
G139 O-Fe G143 N-Fe
G139 0 
-G143 N
G139 0 
-G144 N
D140 0 
-G144 N
rat 
human
biliverdin(Fe)-HO 
heme-HO 
N3 -heme-HO 
heme-HO closed form 
heme-HO opened form
4.9 
5.1 
5.0 
4.8 
4.9
5.2 
4.3 
4.3 
5.3 
6.0
2.9 
3.1 
3.2 
3.2 
3.1
3.8 
2.9 
3.0 
4.3 
4.8
2.8 
3.8 
3.8 
3.1 
2.9
    Distal helix. The F-helix of biliverdin(Fe)-HO-1 was bent (-50°) at Leu-141 and 
Ser-142, as in heme-HO-1 and N3--heme-HO-1, but the middle of the helix, Gly-143 to 
Gln-145, was shifted away from the heme pocket as compared to that in heme-HO-1 and 
N3--heme-HO-1. The distance between Gly-143 N and the iron atom was elongated by 0.9 A 
in biliverdin(Fe)-HO-1 as compared to that in heme-HO-1 and N3--heme-HO-1, whereas the 
distance between Gly-139 0 and the iron atom showed no change in the three structures 
(Table 4). Notably, in biliverdin(Fe)-HO-1 the amide group of Gly-143 was directed toward 
the carbonyl group of Gly-139, forming an a-helical hydrogen-bond (2.9 A). The backbones 
a of Gly-144 and Asp-140 were also hydrogen-bonded (2.8 A) (Figure 4-3, left). In 
N3--heme-HO-1, however, the amide group of Gly-143 is pointed toward the distal ligand 
forming a hydrogen bond (2.8 A), and the amide group of Gly-144 and the carbonyl group of 
0 Gly-139 face each other at a distance suitable for hydrogen-bonding (3.0 A). Moreover, the 
distance between Gly-144 N and Asp-140 0 (3.8 A) is too great o form a hydrogen bond 
(Figure 4-3, right). This unique conformation is also observed in heme-HO-1 (36).
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    Ramachandran plots (85) for the residues from Leu-138 to Val-146 may clarify the 
difference in the F-helix conformations between heme-HO-1 and biliverdin(Fe)-HO-1 (Figure 
4-4). In heme-HO-1 and N3--heme-HO-1, allthe residues examined fell within the region for a 
right-handed a-helical conformation except for Leu-141 ((0, yr) = (-89°, 6°) in heme-HO-1, 
  yr) _ (-87°, 4°) in N3--heme-HO-1) and Ser-142 ((0, yr) _ (-120°, -90°) in heme-HO-1, 
  yr) = (-123°, -98°) in N3--heme-HO-1); the former was on the periphery of the a-helical 
region and the latter was outside of the region. Leu-141 ((0, IV) _ (-74°, -12°)) in 
biliverdin(Fe)-HO-1, was also on the periphery of the region, but the dihedral angles of 
Ser-142 ((0, yr) = (-98°, -58°)) less deviated from the a-helical region as compared to those in 
heme-HO-1 and N3--heme-HO-1. Furthermore, the dihedral angles of the following Gly-143 
((~, iV) = (-101°, -14°)) differed distinctly from those of heme-HO-1 and N3--heme-HO-1 
((~, yr) = (-71°, -25°) in heme-HO-1, (0, yr) = (-60°, -28°) in N3--heme-HO-1). The dihedral 
angles of the other biliverdin(Fe)-HO-1 residues were similar to those in heme-HO-1 and 
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N3--heme-HO-1. That is, the deviations of the dihedral angles between the heme and 
biliverdin(Fe) complexes with HO are limited to two consecutive amino acid residues, 
Ser-142 and Gly-143. Thus, the conformational change in the backbone at these residues in 
biliverdin(Fe)-HO-1 caused the outward shift of F-helix from the heme pocket after this kink 
and also brings about rearrangement of he hydrogen bonds in the kinked region. 
     Proximal helix. The proximal helix of biliverdin(Fe)-HO-1 is shifted slightly away 
from the heme pocket as compared to the helices in heme-HO-1 and N3--heme-HO-1. The 
His-25 ligand of biliverdin(Fe)-HO-1 maintains a conformation similar to those of 
heme-HO-1 and N3--heme-HO-1, and the distance between the iron chelated by biliverdin and 
NE of His-25 (2.4 A) is roughly comparable to the corresponding distances in heme-HO-1 
(2.3 A) and N3 -heme-HO-1 (2.1 A) (Figure 4-3). In heme-HO-1 and N3 -heme-HO-1, the 
amide side-chain of Gln-38 of the B-helix is close enough to form a hydrogen bond with the 
carbonyl group of the backbone of Glu-29 in the A-helix (2.9 A in heme-HO-1, 2.7 A in 
N3--heme-HO-1), indicative that it contributes to fixing the two helices on the proximal side 
of the heme. In biliverdin(Fe)-HO-1, however, the side-chain of Gln-38 is no longer 
hydrogen-bonded to the main-chain of Glu-29 (distance between Gln-38 NE and Glu-29 0 is 
4.4 A) and has moved closer to the pyrrole ring-A of biliverdin(Fe). A similar conformational 
change in the side-chain of Gln-38 occurs in apo-HO as shown in the section 1.1.
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Figure 4-5. Electron density of 
biliverdin(Fe)-HO around the 
hemepocket. 6A weighted 2F,,- Fc 
map contoured at 1.26 (cyan) 
superimposed on the wire-frame 
model of biliverdin(Fe)-HO. The 
6A weighted FO-Fc map contoured 
at 3.56 (red) was calculated by 
omitting the contribution of 
biliverdin(Fe). This figure was 
prepared with MOLSCRIPT 
(125), CONSCRIPT (127), and 
RASTER3D (126).
Figure 4-6. Coordination 
geometry of the iron atom in 
biliverdin(Fe)-HO-1. Dashed 
lines indicate coordination 
bonds to the iron. Numerals 
show distances between atoms 
in angstrom units. Side chains 
of biliverdin(Fe) were not 
shown for clarity. This figure 
was prepared with 
MOLSCRIPT (125) and 
RASTER3D (126).
    Biliverdin-iron cheleate structure. The wire-frame model around the hemepocket of 
biliverdin(Fe)-HO-1 is shown in Figure 4-5. The F,,-Fc map was clearly assignable to the 
electron density of biliverdin(Fe), consistent with the fact that heme cleavage occurs at the
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a-meso carbon. One propionate group of the biliverdin(Fe) adopted the same conformation as 
that of the heme in heme-HO-1 and was buried in the heme pocket, whereas the other group, 
which is exposed to the solvent in heme-HO-1, was disordered. The vinyl group of pyrrole 
ring-A, which is also exposed to solvent in heme-HO-1, was not visible. In addition, the 
temperature factors for the ring-A atoms are higher than those for the other three rings' atoms. 
Taking into account hat all four pyrrole rings of the heme in heme-HO-1 have similar 
temperature factors, the biliverdin(Fe) in biliverdin(Fe)-HO-1 appears to be accommodated 
less tightly in the heme pocket than the heme in heme-HO-1. Biliverdin was in helical 
conformation with the lactam oxygen atoms of ring-A and ring-B that respectively point 
upward and downward. By nature, biliverdin assumes a helical structure to avoid collision 
with the lactam oxygen atoms. The helical pitch of the biliverdin in biliverdin(Fe)-HO- 1,
defined as the distance between the two oxygen atoms, was 3.4 A, comparable to that (3.34 
A) in the crystal structure of biliverdin dimethyl ester (86). A crystallographic study of the 
iron(III) complex of octaethylbilindione (OEB) (87), a chemical model of biliverdin(Fe), 
showed that it forms a dimeric structure, {Fe"II(OEB)}2, in which each iron is five-coordinate 
with bonds to four nitrogen atoms in one tetrapyrrole unit and with a bond to a lactam oxygen 
atom in the partner. Each OEB molecule in {Feni(OEB)}2 has the analogous helical pitch of 
3.22 A, but relatively shorter helical pitches have been reported in biliverdin crystallized with 
proteins; for apoMb (88), 2.9-3.0 A and biliverdin IX(3 reductase (89), 2.8 A. The iron atom in 
biliverdin(Fe) has no distal igand, unlike the heme iron of heme-HO-1 whose distal igand is 
a water molecule or hydroxide. The coordination geometry to the iron atom is shown in 
Figure 4-6. The distances between the iron atom and the nitrogen atoms of the four pyrrole 
0 rings vary considerably, from 2.0 to 2.3 A, as do the coordination angles of the four nitrogen 
atoms about the Fe-NE axis (NA-Fe-NE; 91.4°, NB-NE-Fe; 130.9°, Nc-Fe-NE; 84.5°, 
ND-Fe-NE; 96.3°). This asymmetry of the iron coordination reflects the distorted helical 
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structure of the biliverdin in biliverdin(Fe)-HO-1; the exposed ring-A deviates markedly from 
the mean plane through the biliverdin(Fe) molecule to the distal side, whereas the buried 
ring-B is shifted slightly from the plane to the proximal side.
Figure 4-7. Comparison of the distal hydrogen bond networks in biliverdin(Fe)-HO 
(green) and N3 -heme-HO (light blue). W 1 through W5 indicate the water molecules in 
N3--heme-HO. Dashed lines indicate hydrogen bonds (thin lines: in N3--heme-HO, bold 
lines: in biliverdin(Fe)-HO). This figure was prepared with MOLSCRIPT (125) and 
RASTER3D (126). 
    Protein-biliverdin interactions. In biliverdin(Fe)-HO-1, the carbonyl group of Gly-139 
and the amide group of Gly-143 are no longer in contact with the iron atom due to the 
outward shift of the F-helix and absence of the distal ligand. The a-meso edge of the heme in 
heme-HO-1 faces a hydrophobic wall formed by Met-34, Phe-37, and Phe-214. These 
residues remain unchanged in biliverdin(Fe)-HO-1. On the opposite side of the heme in 
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heme-HO-1, Lys-179, Arg-183, and Lys-18 interact electrostatically with the propionate 
groups of the heme. In biliverdin(Fe)-HO-1, despite disordering of one of the two propionate 
groups, these basic residues retain conformations similar to those in heme-HO-1. In the distal 
heme pocket of heme-HO-1, five water molecules (W1-W5) form a hydrogen-bonding 
network with Asp-140, Arg-136, and Thr-135. This network is completely conserved in 
N3--heme-HO-l, and W1 is hydrogen bonded with the azide ligand (Figure 4-7). In 
biliverdin(Fe)-HO-1, three of the five water molecules (W1-W3) form a hydrogen-bonding 
network with Asp-140 and Arg-136 (Figure 4-7). It should be noted that W1 in 
biliverdin(Fe)-HO-1 is close enough to form a hydrogen bond (2.6 A) with the ring-A oxygen 
of biliverdin. On the proximal side of biliverdin there are no water molecules, and the ring-B 
oxygen does not interact with the protein moieties. 
DISCUSSION 
    Conformational change in the distal helix. One of the intriguing features of the HO-1 
structure is the kinked conformation ofthe distal F-helix, which furnishes a-selectivity to the 
HO reaction (36,39-41). This helix is in close contact with the heme in the holo state (36,39) 
but partially fluctuates in the apo state (90), indicative that the flexibility of this helix 
facilitates both substrate binding and product release. The biliverdin(Fe)-HO-1 structure 
presented here clearly shows that the conformation of F-helix changes to open the heme 
pocket when the a-meso edge of heme is cleaved. This is the first evidence that 
conformational change in the F-helix actually occurs during the HO reaction. The amide 
group of Gly-143 is in close contact with the heme distal ligand in heme-HO-1, whereas in 
biliverdin(Fe)-HO-1 its direction is altered to form a hydrogen bond with the carbonyl group 
of Gly-139, resulting in the outward shift of Gly-143 and the next several residues from the 
heme pocket. This movement is attributable to steric hindrance between F-helix and pyrrole 
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ring-A; Gly-143 will collide with ring-A unless the backbone conformation of the F-helix 
changes. Another possible factor for re-direction of the amide bond of Gly-143 in 
biliverdin(Fe)-HO-1 is loss of the distal water ligand in biliverdin(Fe). Such ligand-dependent 
conformational changes are consistent with the presence of two conformers, opened and 
closed forms, in an asymmetric unit of human heme-HO-1 crystals (40) grown at pH 7.5, 
which is near the pKa of the water ligand bound to the heme iron. Previous RR studies of 
heme-HO-1 complexes suggested that the distal ligand exchange from water to hydroxide 
occurs at pKa, accompanied by high-to-low spin transition of the heme iron (28,29).
Figure 4-8. Superimposition of Ca traces of the distal helices of biliverdin(Fe)-HO 
(green), N3 -heme-HO (red), and the closed (gray) and opened (black) forms of human 
heme-HO. Wire-frame models of biliverdin(Fe) and His-25 in biliverdin(Fe)-HO are 
shown as well as the heme and heme ligands in the human heme-HO-1 open form. All 
models were superimposed to minimize the rms deviations of Cas of all the amino acid 
residues. This figure was prepared with MOLSCRIPT (125) and RASTER3D (126). 
    Comparison with human HO-1 structures. Structural comparison of 
biliverdin(Fe)-HO-1 with human heme-HO-1 molecules (Figure 4-8) shows that the distal 
helix conformation of biliverdin(Fe)-HO-1 is similar to that of the open form (molecule B) of 
human heme-HO-1, consistent with the fact that this human iso-form has an open heme 
pocket with loose interaction between the distal helix and heme (40). In this iso-form, as in 
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biliverdin(Fe)-HO-1, hydrogen bonds are formed between Gly-139 0 and Gly-143 N and 
between Asp- 140 0 and Gly- 144 N (Figure 4-3, Table 4). Interestingly, the distal helix of the 
other human iso-form, the closed form (molecule A), has a conformation similar to that in 
biliverdin(Fe)-HO-1 rather than to the conformations in heme-HO-1 and N3--heme-HO-1. No 
hydrogen bond exists between Gly-139 0 and Gly-144 N in either human HO- I iso-form. 
This agrees with contacts between the distal helix and heme being less tight in the human 
HO-1 closed form as compared with rat HO-1 complexes with heme. The human closed form 
therefore is considered to be a conformation intermediate between that of the rat heme-HO-1 
and human opened form (36,40), and the biliverdin(Fe)-HO-1 structure should be in the 
conformational group with an open heme pocket. 
    Dissociations of iron and biliverdin.Iron release is believed to occur before biliverdin 
dissociation (25). The coordination geometry of the iron in biliverdin(Fe)-HO-1 showed 
substantial distortion from either of the two ideal forms, square-pyramid and 
trigonal-bipyramid, for five-coordinate metal clusters, indicative of the susceptibility to lose 
iron. The iron coordination in {Feni(OEB)}2 (87) approximates a trigonal-bipyramid, but that 
compound is readily demetalated; the iron site has a partial occupancy of 0.56, therefore the 
crystal is apparently comprised of a mixture of {Fe"(OEB)}2 and {Fe"(OEB) (H2OEB)} 
wherein one of the iron ions is lost. Although the iron site was fully occupied in the 
biliverdin(Fe)-HO-1 crystal we studied, iron was partially lost when the crystal was 
over-incubated with sodium ascorbate. Conceivably, the distorted geometry of iron 
coordination in biliverdin(Fe)-HO-1 could facilitate the release of the iron from biliverdin(Fe). 
Based on early work on the degradation of the heme bound to HO in a reaction system with 
ascorbate (25), the iron in the biliverdin(Fe)-HO-1 crystal is probably in the ferric state. A 
kinetic study of the HO reaction (91) showed that product release from HO first requires the 
reduction of Fe 3+-biliverdin to Fe e+-biliverdin; on reduction of iron, rapid release of iron 
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occurs and the slower dissociation of biliverdin follows. Reduction of the iron in 
biliverdin(Fe)-HO-1 may not affect its distorted geometry because the iron(II) complex of a 
methoxy derivative of OEB, {Fe"(OEBOMe)}2 (92), has a structure very similar to that of 
[Fe "(OEB) } 2. The superior solubility of ferrous to ferric iron may be favorable for iron 
release (91,93). 
    The nature of the binding of biliverdin(Fe) in the heme pocket of HO, together with the 
structure of the heme pocket in the apo state (90), gives an insight into a possible mechanism 
for the final product release from the enzyme. Upward movement of the distal helix and 
relaxation of the proximal helix allow the active site to be opened, but several residues 
(Met-34, Phe-37, Phe-214, Lys-179, and Arg-183) that surround the biliverdin(Fe) in 
biliverdin(Fe)-HO-1 have conformations imilar to those in heme-HO-1 and N3--heme-HO-1. 
Conserved interactions between the biliverdin(Fe) and protein moieties of HO are consistent 
with the finding that even in the apo state these residues roughly retain their conformations. 
The position of biliverdin(Fe) also remains unchanged in comparison to the heme positions in 
heme-HO-1 and N3--heme-HO-1. The binding of biliverdin(Fe) in the heme-HO pocket, 
however, is less tight than that of the heme; the porpionate and vinyl groups that are exposed 
to the solvent are invisible in biliverdin(Fe)-HO-1. The loose accommodation of biliverdin is 
accounted for by the opened conformation of the distal helix and the decreased rigidity of the 
tetrapyrrole due to a-meso cleavage. As stated above, the helical pitch of the biliverdin(Fe) in 
biliverdin(Fe)-HO-1 is longer than that of the biliverdin bound to apoMb (88). In contrast o 
the partial exposure of the biliverdin in biliverdin(Fe)-HO-1, the biliverdin in the 
biliverdin-apoMb complex is buried in the Mb heme pocket. Comparison of both biliverdin 
structures bound to proteins shows the marked deviation of ring-A from the mean plane of the 
tetrapyrrole in biliverdin(Fe)-HO-1, indicative that interaction between the ring-A oxygen 
atom and distal hydrogen-bonding network produces the distorted helical structure of 
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biliverdin(Fe). Upon release of the iron, the mechanism of which is unknown, the proximal 
helix should be more relaxed owing to loss of the coordination bond between the iron and 
His-25. Iron release therefore would render biliverdin more flexible, impelling it to a less 
stable accommodation state in the heme pocket. Therefore, the final product release would be 
mainly caused by the increased flexibility of biliverdin assisted by the widening of the active 
site. This scheme suggests low dissociation of biliverdin from the HO active site, which is 
consistent with the finding that biliverdin release is the rate-limiting step of single turnover in 
the HO reaction (91,93).
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1.4 Conclusions 
    I determined rat HO-1 structures of apo-state, azide bound heme complex, as an analog 
of hydrogen peroxide bound heme complex intermediate, and biliverdin-iron chelate complex. 
ApoHO structure shows the fluctuation of A- and F-helices, components of hemepocket, is 
caused by lack of heme. Hydrogen bond between Gln-38 and Glu-29 may be a key to fix the 
HO structure on binding heme. This hydrogen bond is also disrupted in biliverdin-iron chelate 
complex, indicative of the importance of this bond on substrate binding and product release. 
Azide bound heme complex structure clearly indicates that the distal ligand bound to heme is 
directed to the a-meso position of heme and that is mainly caused by steric hindrance by 
unique bending of F-helix. This crucially determines regiospecificity of HO reaction. 
Hydrogen bonding between azide and water molecules in hemepocket also contributes to 
fixing the direction of distal ligand, but these water molecules would be involved in the 
activation of molecular oxygen. Biliverdin-iron chelate complex structure demonstrates that 
HO reaction really proceeds in crystal as in solution, indicating that rat HO-1 in crystal keeps 
its activity. Highly distorted structure of biliverdin-iron chelate suggests that iron is easily 
released to solvent on iron reduction to solubilize in water. The open conformation of F-helix 
and the disruption of hydrogen bond between Gln-38 and Glu-29 in HO-biliverdin(Fe) may 
contribute to smooth release of biliverdin. The structures of these reaction intermediate gave a 
lot of insights in HO reaction, but the structural basis for the steps from a-hydroxyheme to 
biliverdin-iron chelate is not given. The structures of a-hydroxyheme and verdoheme 
complexes would be required for further investigation.
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Chanter 2
Mechanism of escaping from product inhibition in HO
INTRODUCTION 
    Chapter 2 deals with the mechanism how HO discriminates between CO and 02. In HO 
reaction, CO is produced in its second step (Figure 1-3). HO must proceed its reaction in the 
atmosphere where CO is locally concentrated, thus the active site of HO may be equipped 
with a variety of structural devices that allow HO to escape from inhibition by CO. 
    The affinities of such ligands as CO and 02 for the heme iron in hemoproteins vary 
markedly depending on the heme environment. For free heme in organic solvents, the ratio of 
the CO and 02 affinities to the heme iron, the ratio of the CO equilibrium constant (Kco) to 
the 02 equilibrium constant (K02), is about 30,000-100,000 (34,94), whereas in Mb, Kco/Ko2 
is 25-41 (34). A number of structural analyses of oxy and carbomonoxy Mb have shown that 
the discrimination between CO and 02 by Mb is primarily due to hydrogen-bonding and other 
polar interactions rather than steric hindrance (34,95-100). Neutron diffraction 
crystallographic analysis of both forms of Mb indicates that on 02 binding to the heme in Mb, 
the Ne atom of the distal histidine (His E7) is protonated and 02 forms a hydrogen bond with 
His E7 (96), whereas His E7 N6 is protonated on CO binding (97). Recent site-directed 
mutagenesis and spectroscopic analyses, however, suggest hat His E7 NF_ is protonated and 
hydrogen bonded to the distal ligand in both ligand-bound forms (98,99). If so, the 
electrostatic field calculation of heme pocket of Mb indicates good correlations between the 
electrostatic potentials of the distal ligand, the stretching frequencies of infrared absroption 
and RR, and the dissociation rate constants of both ligands in wild-type and mutant Mbs (100). 
Distal pocket polarity therefore would be a key for discrimination between polar 02 and 
apolar CO in Mb. 
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    Studies of 02 and CO bindings to heme-HO, as compared with those of Mb, reported by 
Ikeda-Saito et al. (35), seem exceedingly important; 02 affinities are very high (K02 = 30-80 
µM 1), 30- to 90-fold those for Mb. The 02 association rate constants are similar to those for 
Mb (k'02 = 7-20 µM-1s-1), whereas 02 dissociation rate constants are remarkably slow (k02 = 
0.25 s-1), suggestive of the presence of favorable interactions between the bound 02 and 
protein residues in the heme pocket. In contrast, the CO affinity of heme-HO is reported to be 
similar to that of Mb (35). CO binding to the heme bound to HO is biphasic. The respective 
Kco/KO2 ratios are 5.4 and 1.2 for the fast and slow phases. Thus, HO discriminates much 
more strongly against CO binding with increased affinity for 02 than Mb does. 
    In the first section, I discuss the mechanisms of discrimination between CO and 02 in 
heme-HO. The binding geometry of the ligand to the heme iron, in case of end-on binding, is 
primarily determined by its shape of highest occupied molecular orbiltal (Figure 5-1). This 
theory predicts that the binding mode of 02 is similar to that of N3- and that of NO, while that 
of CO is similar to that of CN. Indeed, RR spectroscopic analysis has given an angle of 
nearly 110° for Fee+.. 04D (50) and the bending angle of N3- is 116° as described in the section 
1.2. To obtain the structural basis of the severe discrimination between 02 and CO in 
heme-HO, I determined the structures of ferrous heme-HO, CO-heme-HO, CN-heme-HO, 
and NO-heme-HO. 
    In the second section, I demonstrate the novel mode of cyanide binding in heme-HO. 
The fact that cyanide binds to the heme iron in unstable fashion at neutral pH suggests the 
steric contribution of the distal helix to the ligand discrimination depending on its binding 
mode.
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 Figure 5-1. Highest occupied molecular orbital (HOMO) of possible heme ligands. 
 Fe.. ligand angle is primarily determined by the shape of HOMO of ligand. Each figure 
 shows ligand (stick model, carbon; green, nitrogen; blue, oxygen; red) and its HOMO 
 (sphere). The orbital color shows the each direction of electron spin. Molecularorbitals 
 were caluculated with the program GAMESS (129). a; 02, b; N3 c; NO (neutralradical), 
 d; NO-, e; CO, f; CN, g; NO+. 
    In the third section,I demonstrate the escaping pathway of endogenously produced CO 
from the hemepocket of HO. One of the notable features of the HO reaction resides in the 
third step, the oxidation of verdoheme to biliverdin; the reaction can proceed without possible 
interference by CO that is produced in the second step, the conversion of a-hydroxyheme to 
verdoheme. The endogenous CO seems never to interfere with the third step in the single 
turnover reaction (91). A markedly low affinity of CO for the verdoheme bound to HO 
compared to that for the heme bound to HO (35) would have to do with the mechanism, 
wherein the possible product inhibition is avoided. However, an excess amount of exogenous 
CO inhibits the third step; the HO reaction substantially ceases at the verdoheme stage under 
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a gas phase of 20% CO and 80% 02 (102). RR spectroscopic study indicates that exogenous 
CO can be directly bound to the verdoheme iron (103). In order to investigate how 
interference of CO is prevented in the third step of HO reaction, I explored CO trapping sites 
and CO releasing pathway in HO. This could be achieved by the structure analysis of the 
short-time photoproduct of CO-heme-HO. Moreover, I also examined the CO releasing 
pathway using molecular dynamics simulation.
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2.1 Structural basis for the discrimination between molecular oxygen and carbon 
monoxide in HO
ABSTRACT 
Heme oxygenase (HO) catalyzes heme degradation by utilizing 02 and reducing equivalents 
to produce biliverdin IXa, iron, and CO. To avoid product inhibition, the heme-HO complex 
is structured to markedly increase its affinity for 02 while suppressing its affinity for CO. I 
determined the crystal structures of rat ferrous heme-HO, heme-HO bound to CO, CN, and 
NO, respectively, at 2.3, 1.8, 2.0, and 1.7 A resolutions. The heme pocket of ferrous heme-HO 
has the same conformation as that of the previously determined ferric form, but no ligand is 
visible on the distal side of the ferrous heme. Fe-CO and Fe-CN- are tilted, whereas Fe-NO is 
bent. The structure of heme-HO bound to NO is identical to that bound to N3, which is also 
bent as in the case of 02. Notably, in the CO and CN- bound forms the heme and its ligands 
shift toward the a-meso carbon, and the distal F-helix shifts in the opposite direction. These 
shifts allow CO or CN to bind in tilted fashion without collision between the distal igand and 
Gly-139 0 and cause disruption of one salt bridge between the heme and basic residue. The 
structural identity of the ferrous and ferric states of heme-HO indicates that these shifts are 
not produced on reduction of heme iron. Neither such conformational changes nor a heme 
shift occurs on NO or N3- binding. Heme-HO therefore recognizes CO and 02 by their 
binding geometries. The marked reduction of the ratio of CO to 02 affinities to heme-HO 
achieved by an increase in 02 affinity is explained by hydrogen-bonding and polar 
interactions favorable for 02 binding, as well as by characteristic structural changes in the 
CO-bound form.
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MATERIALS AND METHODS 
    Preparation of ferrous heme-HO and ligand-bound crystals. The expression and 
purification of truncated rat HO-1 (Metl-Pro267), as well as the preparation of its complex 
with heme, are described in the general introduction (Figure 1-5, (37-39)). Ferric heme-HO 
was crystallized under conditions imilar to those for N3--heme-HO with a microcrystal of 
N3--heme-HO as the seed. Ferrous heme-HO crystals were prepared by soaking ferric 
heme-HO crystals in an anaerobic solution containing an excess amount of sodium dithionite. 
On reduction, the crystal color immediately became bright red. CN-heme-HO was prepared 
by adding potassium cyanide to a ferric heme-HO solution for a final concentration f 10 mM, 
and crystallized under the same conditions used for N3--heme-HO (39), the protein 
concentration being 40 mg ml-1 in 50 mM potassium phosphate buffer (pH 7.0). The 
CO-heme-HO crystal was prepared by soaking an N3--heme-HO crystal in a CO-saturated 
solution until the crystal became bright red (30 m to 2 h). The CO-saturated solution was 
prepared just before soaking the crystals; sodium ascorbate at the final concentration f 100 
mM was added to the crystallization solution then two cycles of alternate de-gassing (15 m) 
and CO-bubbling (5 m) were run. The NO-heme-HO crystal was prepared by soaking the 
N3 -heme-HO crystal in an NO-saturated solution. The crystal immediately became bright red. 
The NO-saturated solution was prepared just before soaking the crystals. Sodium dithionite 
and NOC-12, an NO-donor (Dojindo, Kumamoto, Japan), were added in excess to the 
crystallization solution, the gas phase of which had been replaced with N2 in advance by two 
cycles of alternate de-gassing (15 m) and an N, -purge (5 m). The ferrous heme-HO, 
CO-heme-HO and NO-heme-HO crystals on cryo-loop were immediately cooled with liquid 
nitrogen. The CN--heme-HO crystal was soaked for a few seconds in crystallization solution 
that contained 50 mM potassium cyanide, and then the crystal on cryo-loop was flash-cooled 
under a nitrogen gas stream at 100 K. The CN--heme-HO crystals became bright red on 
soaking them in 50 mM potassium cyanide (final pH was 9.2). 
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    Data collection and processing. Diffraction data for the ferrous heme-HO crystal were 
collected at lOOK with an FR-D rotating anode X-ray generator (X = 1.5418 A) and R-AXIS 
IV" imaging plate system (RIGAKU). Its crystal was oscillated by 1.5° per frame at an 
exposure time of 20 m and total measurement angle of 120°. Diffraction data for 
CN-heme-HO were collected at 100 K using synchrotron radiation (? = 1.000 A) at the 
beamline BL40B2 of SPring-8 and an ADSC Quantum 4R detector. Its crystal was oscillated 
by 1.5° per frame at an exposure time of 120 s and total measurement angle of 60°. Diffraction 
data for CO-heme-HO and NO-heme-HO were collected at 100 K using synchrotron radiation 
(X = 1.000 A) at the beamline BL41XU of SPring-8 and a MarCCD system. For 
CO-heme-HO, the crystal was oscillated by 1.5° per frame at an exposure time of 5 s and total 
measurement angle of 180°. To measure intensities of the overloaded iffractions, the X-ray 
beam was attenuated to 7%, then the same crystal was oscillated by 3.0° per frame with 3 s 
exposure. The two datasets were scaled and merged using 50-1.8 A data for the former and 
50-3.5 A data for the latter. For NO-heme-HO, the exposure time per frame was 6 s and total 
measurement angle was 120°. To collect low resolution data, the X-ray beam was attenuated 
to 25%, then intensity data were collected under the same conditions as for CO-heme-HO. 
The two datasets were scaled and merged using 50-1.7 A data for the former and 50-3.5 A 
data for the latter. These diffraction data were processed, merged, and scaled with MOSFLM 
(56) and SCALA (57,58) for the ferrous heme-HO and CN-heme-HO and with HKL2000 
(77) for CO-heme-HO and NO-heme-HO. Crystallographic data and diffraction statistics are 
given in Table 5. 
    Model building and refinement. Because the CN-heme-HO crystal was isomorphous 
with the N3--heme-HO crystal (39), its structure was determined by applying rigid body, 
simulated annealing, and temperature-factor refinements othe structure of its protein moiety 
using 50.0-2.5 A resolution data. The structure was revised by alternate adjustment of the 
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model by XtalView (78) and simulated annealing and temperature-factor refinements using 
50.0-2.0 A resolution data. The heme, clearly present in the electron density map, was 
included in subsequent refinement. After a few cycles of water picking and energy 
minimization refinements, he electron density for the stretch of Glu-234-Leu-243 appeared 
as a separate density and its model was included in subsequent refinement. Lastly, the cyanide 
ion was located in the F, ,-F, map and included in the energy minimization refinement, in
which neither the Fe • • C-N- angle nor Fe • • C distance was restrained. The structures of ferrous 
heme-HO, CO-heme-HO, and NO-heme-HO were refined by the same procedures 
respectively using 50.0-2.3, 50.0-1.8, and 50.0-1.7 A resolution data. All the refinements were 
done with CNS (60). Stereo-chemical checks of the models were made with PROCHECK 
(57,63). Refinement s atistics are given in Table 5.
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Table 5 Summary of crystallographic statistics of ferrous heme-HO and heme-HO complexes 
                         bound to several ligands
Data set Ferrous heme-HO CO-heme-HO CN-heme-HO NO-heme-HO
Space group 
a=,b= 65.3A 
C = 120.5 A
Resolution (A) 50-2.3 
Unique reflections 13,787 
Redundancy 6.4 
Completeness (%)ttt 99.9 (99.9) 
Rmerge*'ttt 0.102 (0.347) 
R/Rfree t' tt 0.186/0.220 
Rms deviation from ideality 
   bonds (A) 0.006 
   angles (°) 1.14 
Average B-factors (A2) 
   main chain 24.7 
   Side chain 27.2 
   solvent 35.6 
   heme 26.7 
   distal ligand -
       P3221 
  66.0 A 
  120.2 A 
   50-1.8 
  28,853 
   11.8 
99.7 (97.4) 
0.067 (0.315) 
0.195/0.214 
  0.005 
   1.24 
   23.5 
   27.2 
   36.7 
   27.3 
   24.3
  65.7 A 
  119.7 A 
   50-2.0 
  20,629 
     3.5 
99.3 (99.3) 
0.066 (0.284) 
0.198/0.223 
  0.006 
   1.19 
   23.7 
   26.8 
   34.2 
   24.8 
   20.6
  65.4 A 
  121.1 A 
   50-1.7 
  32,251 
     9.5 
99.8 (99.5) 
0.052 (0.346) 
0.201/0.227 
  0.005 
   1.12 
   26.5 
   29.5 
   39.6 
   30.7 
   32.8
*R
merge = Y-hktY-i IIi(hkl) - <I(hkl)>I/Et,kiEili(hkl) 
tR-factor = EIF°bs(hkl) - Featc(hkl)II/EIF°bs(hkl)I 
ttRfree : R values calculated for 5% (ferrous heme-HO and NO-heme-HO) and 10% (CO-heme-HO 
and CN-heme-HO) ofthe dataset not included refinements. 
""Values in parentheses arefor the outermost shell :2.42-2.30 A for ferrous heme-HO, 1.86-1.80A for 
CO-heme-HO, 2.07-2.00 A for CN--heme-HO, and 1.76-1.70 A for NO-heme-HO. 
RESULTS 
    Overall structures. The structures of the ferrous heme-HO, CO-heme-HO, 
CN-heme-HO, and NO-heme-HO have been refined, respectively, at2.3 A resolution to an 
R/Rfree of 0.186/0.220; at 1.8 A resolution to an R/Rfree of 0.195/0.214; at2.0 A resolution to 
an R/Rfree of 0.198/0.223; and at 1.7 A resolution to an R/Rfree of 0.201/0.227. In 
CN--heme-HO, the C-terminal loop (Glu-234-Leu-243) has become ordered, but the side 
chains of Glu-234 and Arg-237 are still disordered. This loop is located at the back of the 
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heme pocket. The distance (30 A) between Thr-222 and Glu-234 indicates that he disordered 
segment (Glu-223-Thr-233) assumes an extended conformation. The side chain of Lys-177 is 
disordered in each of the CO-, CN- and NO-heme-HO crystals. In CO-heme-HO and 
NO-heme-HO, the side chain of G1u-190 is disordered. In CO-heme-HO, the side chains of 
Glu-19 and Glu-45 are also disordered. In NO-heme-HO, there are several alternate 
conformations for the side chains on the molecular surface and an additional NO molecule 
near the side chain of Arg-27. In N3--heme-HO, an additional azide molecule was also found 
to bind to the same site (39). In the ferrous heme-HO structure, no electron density is present 
on the distal side of the heme iron, consistent with previous pectroscopic study findings 
(29,30,104). 
    Structural comparisons of the various forms of heme-HO are shown in Figure 5-2. The 
overall structure of ferrous heme-HO is identical to that of N3--heme-HO (39) (Figure 5-2a) 
and similar to that of ferric heme-HO (36), the respective root mean square (rms) deviations 
for the Ca atoms being 0.13 and 0.46 A. The relatively large rms deviation between the 
ferrous and ferric heme-HOs is mainly due to the different conformations in the FG and GH 
loops on the molecular surface; the rms deviation is 0.28 A when these loops are excluded. 
The space groups of the ferrous and ferric heme-HO crystals differ and these loops are 
involved in intermolecular contacts. The structural difference in these loops therefore would 
be due to the crystal packing force. NO-heme-HO also has the same structure as ferrous 
heme-HO (Figure 5-2a), the rms deviation being 0.13 A. The heme position remains 
unchanged on NO binding to the ferrous iron as it does on N3" binding to the ferric iron (39). 
It may be concluded that neither the oxidation state of the heme iron nor substitution of the 
distal igand of heme-HO by NO or N3- affects the HO structure. 
    Superimposition f the ferrous heme-HO and CO-heme-HO structures (Figure 5-2b) 
shows that on CO binding the heme shifts (0.9 A) toward the a-meso carbon along the a-y 
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axis of the heme. The plot of deviations for Ca atoms between ferrous heme-HO and 
CO-heme-HO (Figure 5-2a) shows marked differences in positions of the A-, B-, F-, and 
G-helices which constitute the heme binding site of HO. In CO-heme-HO, the proximal A-
and following B-helices move in the direction of the a-meso carbon together with the heme 
shift, whereas the distal F- and G-helices hift in the opposite direction; e.g., the Ca atoms of 
His-25 in the A-helix and Gly-143 in the F-helix are located at 0.5 and 1.1 A, respectively, 
from their positions in the ferrous heme-HO. Because no significant structural change occurs 
in the heme pocket on NO binding to the ferrous heme, these heme shift and conformational 
changes on CO binding are attributable to the difference in the coordination modes of the 
ligands. 
    The structure of CN--heme-HO, as compared with that of the ferrous heme-HO, also 
shows large deviations at residues located in the heme pocket (Figure 5-2a). It is similar to the 
structure of CO-heme-HO; the rms deviation for Ca atoms between the CO- and CN-bound 
forms is 0.29 A. The heme shift, accompanied bymovement of the A- and B-helices, in the 
a-meso direction, and repositioning ofthe F- and G-helices occurs in heme-HO-CN- as it does 
in CO-heme-HO. Taking the ferric state of the heme iron in CN-heme-HO into account, it is 
conceivable that the binding modes of CO and CN, not the redox states of the heme iron, are 
responsible for these conformational changes.
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Figure 5-2. Structural comparisons of various forms of heme-HO. a. Plots of Ca atom 
deviations between ferrous heme-HO and ligand-bound heme-HOs; N3 -heme-HO (red), 
NO-heme-HO (green), CO-heme-HO (black), and CN--heme-HO (blue). Solid horizontal 
bars indicate the helices in the ferric heme-HO. b. Stereo diagram of Ca traces of ferrous 
heme-HO (blue) and CO-heme-HO (red). The models are superimposed to minimize the 
rms deviation of the corresponding Cas of all the amino acid residues. Figure 5-2b was 
prepared with MOLSCRIPT (125) and RASTER3D (126).
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a.
b.
c.
d.
D140 D140
D140 D140
Figure 5-3. Structures 
of CO-heme-HO, 
CN heme-HO, 
NO-heme-HO, and 
ferrous heme-HO 
around the heme 
pockets. 6A weighted 
2F0F (cyan) and FF 
(red) maps 
superimposed onthe 
wire-frame model are 
shown in stereo-view. 
Dashed lines show the 
hydrogen and 
coordination bonds 
involved in 
stabilization ofdistal 
ligand binding. a; 
CO-heme-HO, b; 
CN--heme-HO, c;
NO-heme-HO, d; 
ferrous heme-HO. Each 
2F F map is 
contoured at 1.2 6 , 
whereas the Fo F map 
at 5.0 a was calculated 
by omitting exogenous 
ligand bound to the 
heme iron. Fe ... C(CO) 
and Fe ...C(CN-) 
distances are in 
angstrom units. These 
figures were prepared 
with MOLSCRIPT 
(125), CONSCRIPT 
(127), and RASTER3D 
(126).
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    Ligand coordination modes. In the F, ,-F, map of CO-heme-HO the ellipsoidal density 
on the distal side of the heme iron, assignable tothe CO molecule, istilted toward the a-meso 
carbon (Figure 5-3a). The Fe • • GO angle has converged to 158° and the Fe • Clength to 2.0 A 
by refinement. This tilt geometry is comparable to the Fe • • GO angle (- 160°) obtained by 
infrared measurements (34) and recent high-resolution X-ray analysis (95) for CO-bound Mb. 
Due to repositioning of the heme and distal helix, the distance between Gly-143 N and the 
carbon atom of CO is lengthened to3.5 A in comparison tothe close contact (2.8 A) between 
Gly-143 N and the iron-bound nitrogen atom of the azide in N3--heme-HO (39). The oxygen 
atom of CO is in van der Waals contact with Gly-139 O (2.9 A) and Gly-144 N (3.1 A0). In the 
distal pocket of CO-heme-HO, the five ordered water molecules present in heme-HO 
(36,40,41) and N3--heme-HO (39) are conserved. These water molecules are involved in the 
hydrogen-bonding etwork that is considered to be important for catalyzing hydroxylation of
0 the a-meso position of heme (81,82). One of these ordered water molecules i  located 2.9 A 
from the oxygen atom of CO. 
    CN- is coordinatedtothe heme iron in the same mode as CO; the Fe • • C-N angle is 166°, 
the Fe • C distance 2.1 A (Figure 5-3b). The tilt angle (-20°) and direction of CN are roughly 
consistent with the magnetic axis determined by NMR spectroscopy for human 
CN-heme-HO (105). Cyanide anion is accommodated in the heme pocket in a manner similar 
to the CO in CO-heme-HO. The iron-bound carbon atom of CN is 3.6 0A from Gly-143 N, 
whereas the terminal nitrogen atom is in van der Waals contact with Gly-139 0 (2.8 A) and 
Gly-144 N (2.8 A). A hydrogen-bonding etwork is also present in CN-heme-HO and the 
distance between CN and the nearest water molecule is 2.6 A. 
    In contrast, in NO-heme-HO, NO is bent toward thea-meso carbon of the heme; the 
Fe • N-0 angle has converged to 125° and Fe • • Nlength to 2.1 A by refinement (Figure 5-3c). 
This bent geometry is comparable to the coordination of azide to the heme iron in 
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N3--heme-HO, in which the corresponding angle is 116°and length is 2.2 A (39). The nitrogen 
atom of NO is hydrogen-bonded to Gly-143 N (2.8 A) and in a van der Waals interaction with 
Gly-139 0 (2.9 A) as is the iron-bound nitrogen of azide in N3--heme-HO. The oxygen atom 
of NO is 2.8 A from Gly-139 0, 3.2 A from Gly-144 N, and 2.9 A from a water molecule in 
the hydrogen-bonding network. 
    Water moleculesconsisting of such distal hydrogen-bonding network are also present in 
ferrous heme-HO, but the distal igand is lacking (Figure 5-3d). Electron density for five of 
the six water molecules in this hydrogen-bonding etwork is broad (Figure 5-3d), indicative 
of fluctuation of these water molecules.
Figure 5-4. Structural changes on CO binding. Stereo diagram around the heme pockets 
of CO-heme-HO (red), CN--heme-HO (blue), and ferrous heme-HO (gray). The models are 
superimposed to minimize rms deviations of the Cots of all the amino acid residues. The 
A-, F-, and G-helices are shown as Ca traces, and Lys-18, His-25, Lys-179, Arg-183, 
heme, CO, and CN as a wire-frame model. This figure was prepared with MOLSCRIPT 
(125) and RASTER3D (126).
    Interactions of propionate groups with basic residues in the heme pocket. The current 
structures of the various ligand-binding forms of heme-HO show that the binding modes of 
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ligands affect the electrostatic nteractions of the propionate groups of the heme with side 
chains that have important roles for the correct accommodation f heme in the active site 
(36,40). Lys-18, Lys-179, and Arg-183 are clustered near the propionate groups in the ferric 
(36,40) and ferrous heme-HO complexes and in N3 -heme-HO (39). The structures of these 
basic residues are unaffected by the bound NO. The side chains of Lys-179 in CO-heme-HO 
and Lys-18 in CN--heme-HO, however, have different conformations and no longer interact 
with the propionates (Figure 5-4). The present refinement for NO-heme-HO includes only the 
major orientation of heme, though additional electron density of the heme is observed as in 
N3--heme-HO; the heme has two orientations related to each other by 180° rotation about he 
a-y axis. One propionate group exposed to solvent has two conformations, both of which are 
directed to the distal side. Dual orientations and conformations are not seen in the present 
X-ray analyses of CO- and CN-heme-HO. Based on NMR analysis (105), however, there are 
two orientations of heme in CN-heme-HO. The propionate xposed to solvent is directed 
toward the proximal side in CO- and CN--heme-HO. In addition, the a-y axis of the heme in 
CO- and CN-heme-HO is slightly rotated along the axial axis as compared to the (X-'Y axis in 
N3--heme-HO. Consequently the a-meso carbon and propionate group are more exposed to 
the solvent.
DISCUSSION 
    The most notable feature of CO and CN binding to the heme bound to HO is gross 
relocation of the active site accompanied by a heme shift. Although a heme shift on ligand 
binding has been reported in dimeric clam Hb, it is involved in cooperative ligand binding 
through residues on the subunit interface that link the heme of one subunit to the proximal 
helix of the second subunit (106). The tilt geometry of CO or CN in the distal pocket of 
heme-HO would produce steric hindrance between CO or CN and the distal helix, if the 
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locations of both the protein and heme remain unchanged; the oxygen atom of CO or the 
nitrogen atom of CN would collide with Gly-139 0 (2.0 A). To avoid such steric hindrance, 
the heme and its ligands shift along the a-y axis of the heme, and the distal F-helix shifts in 
the opposite direction. These shifts accompany the G-helix shift. Such structural changes 
disrupt he salt bridge between the heme and protein in heme-HO (Figure 5-4). Most likely 
gross structural change is induced by ligands such as CO which coordinates to the heme in 
HO in a tilt manner, as shown in Figure 5-5. 
                                         shift
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           Figure 5-5. Possible model for CO binding to the heme iron. 
    Recent NMR studies of the CN bound forms of human HO in complexes with heme 
(105) and its symmetric derivative (107) show that the central portion of the distal helix is 
closer to the heme in the solution structure than it is in the crystal structure of human 
heme-HO, with the position in solution more closely resembling that in the crystal structure of 
0 rat heme-HO. The likely movement ofthe distal helix by -0.5 A closer to the heme iron (107) 
is consistent with a difference in the positions of the distal helix of the crystal structures ofrat 
and human HOs. The distance between Gly-143 N and the heme iron is 4.9 A in rat 
CN--heme-HO in this study, whereas the distances in the two molecules of human heme-HO 
in an asymmetric unit (40) are 5.3 and 6.0 A. NMR studies also show that the four-ring 
aromatic luster (Tyr-58, Tyr-137, Phe-166, and Phe-167) moves closer to the heme, but no 
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rearrangement of the aromatic luster occurs in rat heme-HO on the binding of various 
ligands, including CN. 
    Unlike CO and CN, NO coordinates to the heme iron in bent geometry in 
NO-heme-HO as does N3" in N3-heme-HO (39). NO binding to heme-HO causes no 
significant change in the conformation ofthe heme binding site or in the heme position. As to 
the Fe • • N O angles in the model heme compounds, there are three types depending on the 
number of metal d-electrons plus the electron in the n* orbitals of NO (108,109); -180' in 6 
(ferric heme-NO), -140° in 7 (ferrous heme-NO), and -120° in 8. In NO-heme-HO, as in 
NO-bound Mb (108,109), NO is more bent compared to the ideal geometry, indicative of 
increased it-bonding between the heme iron and NO. 02 also prefers a bent geometry; a
previous RR study of the oxy heme-HO revealed that bound 02 assumes a bent geometry with 
an Fe • • 0-0 angle of _ 110° (50). NO-heme-HO, as well as N3--heme-HO, therefore, would be 
a suitable analog for examining the binding mode of 02 and molecular oxygen activation in 
the HO reaction. On account of the a-meso orientation of NO, the oxygen atom of NO is in 
close contact with the a-meso carbon (3.5 A), suggesting that the distal oxygen atom of 
hydrogen peroxide, the active oxygen species for a-meso hydroxylation, can easily attack the 
a-meso carbon directly. 
    Generally, the main factors regulating the CO and 02 affinities of a hemoprotein are the 
shape of heme pocket (steric hindrance), hydrogen bonds, and polarity of the heme pocket 
(110). Studies for 02 and CO bindings to heme analogs to evaluate these three effects have 
shown that steric hindrance that bends the Fe • • CO bond decreases the binding affinity for CO 
whereas the affinity for 02 is unaffected. Hydrogen bonding to the distal ligand and the 
polarity in the heme pocket, however, increase the binding affinity for 02 whereas the affinity 
for CO is unaffected (110). In the case of HO, strict discrimination between 02 and CO is 
mainly brought about by an increase in 02 affinity that is characterized bya remarkably slow 
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02 dissociation rate constant (35). Comparison of the distal environments of the CO- and 
NO-bound forms clearly shows that the hydrogen bond between Gly- 143 N and NO is present 
in a bent geometry but such interaction is no longer seen in the tilt geometry (Figure 5-6). 
Although the biochemical data for the affinity for NO of ferrous heme-HO are not available, 
its affinity of ferric heme-HO was reported to be higher than that of met Mb (111). The 
binding affinity of NO to the iron atom of hemoproteins is generally much higher in the 
ferrous state than in the ferric state (112,113). In addition, NO binding is stabilized by the 
hydrogen bond to water (Figure 5-3c). Its affinity of ferrous heme-HO would be greater than 
that of Mb. Because of the highly bent structure for 02 coordination, Gly-143 N would form a 
hydrogen bond with the iron-bound oxygen atom of 02, which would stabilize 02 
coordination to the heme iron thereby decreasing the 02 dissociation rate constant.
Figure 5-6. Superimposition of the 
heme distal sides of CO-heme-HO 
and NO-heme-HO. Ball and stick 
model for heme, ligands, Gly- 139, 
Gly-143, and Gly-144 of 
NO-heme-HO (carbon and iron are 
black, nitrogen is blue, and oxygen is 
red) is superimposed on that of 
CO-heme-HO (transparent light gray). 
The dashed line indicates the hydrogen 
bond between Gly 143 N and the 
nitrogen atom of NO in NO-heme-HO. 
The porphyrin substituents are omitted 
for clarity. The figure was prepared 
with MOLSCRIPT (125) and 
RASTER3D (126).
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Consequently, I conclude that it is the hydrogen-bonding of Gly-143 N with 02 which 
primarily controls ligand discrimination by HO. 
    Moreover, aseries of polar interactions may increase the binding affinity for 02 of HO. 
Gly-139 0 and Gly-144 N are in van der Waals contact with the ligands in both coordination 
geometries, indicative that these polar groups may exert a preference for a polar 02 as 
compared to an apolar CO. One of the ordered water molecules in the distal 
hydrogen-bonding network is also located within 3 A of the distal igands in both geometries. 
This hydrophilic network has the ability to donate hydrogen to the heme ligand and has been 
speculated to be essential for catalyzing hydroxylation of the a-meso position of heme 
(39,81,82). Probably, the polarity of this network also contributes to increase the binding 
affinity for 02 in heme-HO. For tilt-type ligands such as CO, however, the stabilization 
gained by the hydrogen bond between the terminal atom of the ligand and one of the water 
molecules in the conserved network may be cancelled, at least in part, by the disruption of the 
salt bridge between the heme propionate and basic residue caused by the heme shifts (Figure 
5-4). This may result in the affinity for CO in HO being comparable tothat in Mb.
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2.2 Two cyanide b inding modes in heme-HO
ABSTRACT 
As described in the previous section, HO have structural devices to discriminate between 02 
and CO. That is, the structure of HO hemepocket is unfavorable to the ligand binding in 
tilt-mode. The structure drastically changes depending on the ligand binding modes. Cyanide, 
as CO, generally binds to the heme iron in tilt-mode. Indeed, at alkaline pH, cyanide binds to 
heme-HO in tilt-mode as shown in the previous section. However, I demonstrate here that 
bent-binding mode of cyanide was observed in heme-HO crystal at neutral pH. In this case, 
neither structural change of the protein nor the heme shift was observed on cyanide binding. 
This novel cyanide binding mode have not been observed in other ferric hemoproteins to my 
knowledge. RR spectrum of these crystals and X-ray crystallography illuminating by red laser 
at cryogenic temperature showed that cyanide bound to heme-HO in bent-mode is readily 
photolyzed. These results suggest that unstabilization to adopt bent-binding of cyanide in 
heme-HO is nearly equal to that to disrupt the interactions between the propionate groups of 
heme and basic residues of HO.
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MATERIALS AND METHODS 
    Crystallographic analysis of CN-heme-HO. CN-heme-HO was crystallized as 
described in the section 2.1 (114). CN--heme-HO crystals at several pHs were prepared by 
soaking co-crystallized CN-heme-HO for a few minutes in each solutions; 5 mM KCN; 
crystallization solution (4 M sodium formate, 5 mM potassium cyanide, and 50 MM 
potassium phosphate (pH 6.8)), 10 mM KCN; crystallization solution containing 10 mM 
potassium cyanide, 20 mM KCN; crystallization solution containing 20 mM potassium 
cyanide, 40 mM KCN; crystallization solution containing 40 mM potassium cyanide, 50 mM 
KCN; crystallization solution containing 50 mM potassium cyanide, 5 mM KCN (pH 9.7); 
crystallization solution replaced potassium phosphate by sodium borate (pH 9.7). 
    Diffraction data for CN-heme-HO crystals at several pHs werecollected using 
synchrotron radiation (?, = 0.750 A) at 100K at the beamline BL41XU, SPring-8 and a 
MarCCD detector. The distance between the crystal and CCD was 170 mm. To cover wide 
range of diffraction intensities, two datasets were collected from one crystal within total 
oscillation angle of 120°; one was collected by oscillating the crystal by 1.5° per frame and the 
other by 3.0° per frame with attenuated X-ray dose. Diffraction data for CN--heme-HO 
crystals in the dark and under illumination by red laser were collected using synchrotron 
radiation (X = 1.000 A) at -35 K using an open flow He cryostat (115) at the beamline 
BL44B2 of SPring-8 and a MarCCD detector. For the data collection under illumination, 
crystal was continuously illuminated for 10 min before and during the data collection by red 
light produced by a He-Ne laser (15 mW, 632.8 nm; Melles Griot, Irvine, CA). The distance 
between the crystal and CCD was 130 mm. The crystal was oscillated by 1.5° per frame, total 
measurement angle of 90°. To increase the signal-to-noise ratio of difference Fourier map, the 
datasets for CN--heme-HO in the dark and under illumination were collected from the same 
crystal under the same conditions. Diffraction data were processed, merged, and scaled with 
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HKL2000 (77). The model refinements of CN-heme-HO (pH 6.8) were performed with the 
program CNS (60). Difference Fourier maps between in the dark and under illumination were 
calculated using CCP4 suite (57). Diffraction statistics, and refinement statistics are given in 
Table 6. 
    RR spectrum. RR scattering was excited at 423.0 nm. The 423.0 nm beam was obtained 
by doubling the Ti-sapphire laser output at 846.0 nm (repetition rate; 82 MHz, pulse width; 
130 fs) with a KNbO3 crystal thermostated at -11 °C. Raman scattering was dispersed by a 
single polychromator (Ritsu Oyo Kogaku MC-100DG, with a focal length of 1000 mm) and 
detected by an intensified photodiode array (Princeton Applied Research HQ-1421B). A 
cylindrical spinning cell (1200 rpm) with an inner diameter of 3 mm was used to avoid local 
heating of the solution samples. The laser power at the cell was 1.0 mW. A homemade 
confocal microscopic device was used to crystalline samples. To avoid local heating of the 
crystalline samples, sample was cooled with the N2 gas stream through liquid N2.
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Table 6 Summary of crystallographic statistics of CN--heme-HO
CN--heme-HO 
  (pH 6.8)
Photolysis of 
CN--heme-HO 
  (pH 6.8)
Photolysis of 
CN--heme-HO 
  (pH 9.7)
Diffraction statistics 
  Resolution range (A) 
  No. of observations 
  No. of unique reflections 
  Redundancy
  Completeness (%)* 
  Mean 1 jig 
  Rsymt> 
Refinement s atistics 
  R/Rfreett 
 Rms deviations from ideality 
     bond lengths (A)
     Angles (deg)
 50.0-1.85 
 215,344 
  25,213 
     8.5 
95.7 (89.3) 
   15.6 
0.046 (0.335)
0.194/0.218
0.006 
1.138
In the dark Laser on 
       20.0-2.0 
 108,693 107,876 
 19,018 19,152 
   5.7 5.6 
  92.3 92.8 
 (87.2) (92.2) 
  13.8 13.4 
 0.080 0.083 
 (0.423) (0.417)
In the dark Laser on 
       20.0-2.0 
 97,643 92,256 
 18,922 18,744 
   5.2 4.9 
  91.1 90.2 
 (86.9) (84.3) 
  15.3 17.4 
 0.060 0.061 
 (0.400) (0.420)
t Rsym = EsxiE1 II1(hkl) - <I(hkl)>I / Eu1 I((hkl), <I(hkl)> is the mean intensity for multiple recorded 
reflections. 
t' R = EJFobs(hkl) - Feale(hkl) / EIFobs(hkl)I. 
Each Rfree isthe R value calculated for ten percent of the dataset not included in the refinement. * V
alues in parentheses are for the outermost hell. 
RESULTS AND DISCUSSION 
    The bent- and tilt-binding modes of cyanide were observed in the crystal depending on 
the solution conditions as shown in Figure 6-1. The structure of CN-heme-HO in bent-mode 
was similar to that of NO-heme-HO where structural shift does not occur, whereas that in 
tilt-mode was similar to that of CO-heme-HO where structural shift occurs as described in 
section 2.1. (114). Tilt-binding of cyanide was observed in the KCN concentration of 20-50 
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Figure 6-1. Two different binding modes of cyanide binding in HO. F,,-F, map 
omitting distal ligand is superimposed on the ball-and-stick model around heme. a; 
Bent binding mode: 5 mM cyanide and pH 6.8. b; Tilt binding mode: 50 mM cyanide and 
pH 9.7. These figures were prepared with MOLSCRIPT (125), CONSCRIPT (127), and 
RASTER3D (126). 
mM and pH 7.8-9.7, while bent binding was observed in the KCN concentration of 5-10 mM 
and pH 6.8-7.1. This difference of binding mode would be caused by pH because tilt-binding 
of cyanide was also observed only when pH was changed to alkaline (pH 9.7). Although 
determination of the bending angle of distal ligand requires more precise analysis at higher 
resolution, in heme-HO, two ligand binding modes are clearly determined because it is 
coupled to the structural change. Tilt-bindng mode of cyanide in solution based on NMR 
analysis (pH 8.0) is consistent o this result (105,107). 
    Two ligand binding modes of cyanide in heme-HO were proved by X-ray analysis as 
shown in the previous paragraph, however, it was not proved that this is also occurred in 
solution. To study further the two alternative modes of cyanide binding, I measured the 
high-frequency RR spectrum for CN-heme-HO both in solution and in crystal. In result, there 
is no significant difference depending on pH in solution (Figure 6-2 (A)-(F)), whereas drastic 
difference was observed in crystal depending on pH (Figure 6-2 (G)-(I)). RR spectrum in 
crystal at alkaline pH was similar to that in solution, but in neutral pH, the spectrum is similar 
to that of ferric heme-HO solution (29,104). Features of RR spectrum in crystal would 
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indicate that cyanide bound to heme-HO at neutral pH was photodissciated by laser 
irradiation using measurements. This clearly shows the cyanide binding mode in heme-HO 
differs depending on pH at least in crystal. 
    RR spectrum in solution did not show such photodissociation by exciting light, but it 
should be caused by technical reason. In crystal, exciting laser continuously illuminated 
sample for measurements at one position, but sample in solution was convecting. Thus the 
dose of laser irradiation to the sample for the measurement of RR in crystal was markedly 
greater than that in solution. In addition, it would be conceivable that two cyanide binding 
modes could not detect in this RR measurements in solution because RR spectrum in the 
high-frequency region does not directly reflect the coordination bonds between cyanide and 
heme iron. RR spectrum in the low-frequency region, which directly reflect the coordination 
bonds, is required for further study in solution. 
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    To check that RR spectrum of CN-heme-HO crystal at neutral pH resembles the 
photolysis of CN-heme-HO, I collected the X-ray diffraction data in the dark and under laser 
illumination. Difference Fourier maps (Figure 6-3) clearly show that cyanide at the distal side 
of heme at neutral pH was dissociated from heme iron by laser irradiation but not dissociated 
at alkaline pH under the same experimental conditions. Although the wavelengths of exciting 
light in RR and X-ray experiments differ, it was shown that cyanide bound to heme iron in 
bent-mode is readily dissociated by laser irradiation. This indicates that the Fe-CN- bond of 
bent-mode is weaker than that of tilt-mode.
Figure 6-3. Photo-dissociation of CN--heme-HO in crystal. Difference Fourier map 
calculated between two datasets, in the dark and continuously illuminating by red laser, is 
superimposed on the ball-and-stick model around heme. Heme is colored green and cyanide 
model is not included. Positive and negative densities indicate the densities that were 
increased and decreased, respectively, upon laser irradiation. (red; contoured at -3a, 
blue; +3(7). a; 5 mM KCN, pH 6.8, b; 50 mM KCN, pH 9.7. This figure was prepared with 
MOLSCRIPT (125), CONSCRIPT (127), and RASTER3D (126).
    These results indicate that there are two binding modes of cyanide in heme-HO 
depending on pH at least in the crystal. Unstable bent-binding of cyanide would be forced by 
the steric hindrance between the distal helix and cyanide. This indicates that the structural 
change, which occurs in the tilt-binding mode, needs to overcome the energy barrier. Energy 
to force the bent-binding of cyanide and that to cause the structural change of the heme and 
distal helix would be nearly equivalent. One reason why the binding-modes of cyanide are 
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dependent on pH may be that the basic residues in HO and the propionate groups of heme 
may change their protonated states depending on pH. That is, the change of protonation of 
these groups may change the strength of the salt-bridges between the propionate group of 
heme and the basic residues.
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2.3 Trapping sites of endogenous carbon monoxide in 
photodissociation of ferrous heme-HO bound to carbon monoxide
HO revealed by the
ABSTRACT 
Heme oxygenase (HO) catalyzes physiological heme degradation using 02 and reducing 
equivalents o produce biliverdin, iron, and CO. Notably the HO reaction proceeds without 
product inhibition by CO, which is generated in the conversion of a-hydroxyheme to 
verdoheme, although CO is known to be a potent inhibitor for HO as for other hemoproteins. 
In order to probe how the endogenous CO is released from the reaction site, I collected X-ray 
diffraction data of the crystal of the CO bound form of the ferrous heme-HO complex in the 
dark and under illumination by red laser at -35 K. The difference Fourier map indicates that 
the CO ligand is partially dissociated from the heme by laser irradiation and that CO is 
trapped in a hydrophobic cavity adjacent to the heme pocket. Taking much weaker affinity of 
CO for the ferrous verdoheme-HO complex compared to that for the ferrous heme complex 
into consideration, the CO derived from a-hydroxyheme would be preferentially trapped in 
the hydrophobic cavity but not coordinated tothe iron of verdoheme. This structural device 
would ensure asmooth progress of the subsequent reaction step, from verdoheme tobiliverdin, 
which requires 02 binding to verdoheme.
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MATERIALS AND METHODS 
    X-ray crystallographic analysis of CO-heme-HO in the dark and under illumination. 
Truncated rat HO-1 (Met-1--Pro-267) was expressed and purified as described in the general 
introduction (Figure 1-5, (39)). CO-heme-HO crystal was prepared as described in the section 
2.1 (39,114). CO-heme-HO crystal was handled with a cryo-loop and cooled with liquid 
nitrogen. The frozen crystals were stocked in liquid nitrogen until the data collection. 
Diffraction data of CO-heme-HO in the dark and under illumination were collected as well as 
that of CN-heme-HO as described in the previous ection. Diffraction data were processed, 
merged, and scaled with HKL2000 (77). The model of photolyzed intermediate was refined 
with CNS (60), where positions and orientations of photodissociated CO were fixed. CO 
occupancies of the photolyzed CO-heme-HO were estimated by this difference Fourier map, 
F,, F, map, and refinement where CO occupancies were varied with fixing the temperature 
factors of CO at reasonable values (25 A2 for CO bound to the heme iron and 40 A2 for CO at 
the site-1 and site-2). The model was refined with the program CNS and CCP4 suite (57). The 
volumes of the solvent-accessible distal pocket were calculated using the program VOIDOO 
(116), whereby the probe radius used was 1.4 A. Crystallographic data, diffraction statistics, 
and refinement s atistics are given in Table 7. 
    Molecular dynamics simulation. Diffusion pathway of the dissociated CO was 
simulated using the program NAMD (117). Hydrogen atoms were added automatically tothe 
atoms in CO-heme-HO model using the program CNS (60). Water molecules were 
additionally generated in the model as wrapping whole protein moiety. Total number of atoms 
using in the simulation was 9,914. After the energy minimization of the model, molecular 
dynamics simulation was started at 0 K, then warmed up 50 K per ps until the tempature was 
reached to 300 K. Force field parameters in the program package CNS were applied for 
protein and water (TIP3). Parameters for heme was slightly modified from those in the 
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program package CHARMM22 (118) 
CO-heme-HO. Electrostatic interactions 
Simulation was continued by 200 ps.
to accommodate he conformation of heme in 
beyond 12 A were omitted from the calculations.
Table 7 Summary of crystallographic statistics
Crystallographic data 
  Crystal system 
  Space group 
  Unit cell dimensions (A) 
  No. of molecules in an asymmetric unit 
Diffraction statistics 
  Resolution range (A) 
  No. of observations 
  No. of unique reflections 
  Redundancy
  Completeness (%)* 
  Mean Iol6 
  R t. 
     sym
     Trigonal 
     P3221 
a = b = 65.9, c = 120.1 
1
In the dark 
  20-2.0 
 102,919 
 17,807 
   5.8 
84.9 (87.2) 
  18.8 
 0.059 
 (0.350)
Laser on 
 20-2.0 
 102,900 
 17,805 
   5.8 
84.8 (87.0) 
  18.6 
 0.060 
 (0.359)
Refinement statistics of the photolyzed CO-heme-HO 
 R/R * 0.207/0.239 
  Rms deviations from ideality 
     bond lengths (A) 0.007 
     angles (deg) 1.20
t Rsym = EhkI i II;(hkl) - <I(hkl)>I / Ehk1E;I;(hkl), <I(hkl)> is the mean 
intensity for multiple recorded reflections. 
$ R = EIFobs(hkl) - Fcalc(hkl) / EIFobs(hkl)I. 
Each Rfree is the R value calculated for ten percent of the dataset not 
included in the refinement. . V
alues in parentheses are for the outermost hell (2.07-2.OOA).
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RESULTS AND DISCUSSION 
    CO trapping site. Difference Fourier map for CO-heme-HO between in the dark and 
under illumination is shown in Figure 7-1. Positive density on the heme distal side indicates 
the photolysis of CO-heme-HO by laser irradiation. On the other hand, negative densities 
were observed at two sites, one above the pyrrole ring of heme (site-1) and another at the 
hydrophobic cavity adjacent to the heme pocket (site-2). The negative densities in the site-1 
and site-2 were found at -5 and -10 A apart from the heme iron, respectively. It would be 
hard to distinguish whether the density at the site-1 originated from CO or from water. 
However, CO molecules photodissociated from carbonmonoxy Mb (119-123) and Hb (124) 
are trapped at the corresponding site. Therefore I consider that the density at the site-1 is due 
to the CO dissociated from CO-heme-HO on photolysis. 
    Site-2, which is surrounded by such hydrophobic residues as Met-34, Phe-37, Val-50, 
Met-51, Leu-54, Leu-147, and Phe-167 (Figure 7-Ib), is conserved in the structures ofhuman 
HO-1 (40,76), Corynebacterium diphtheriae HO (HmuO) (PDB ID; iIWO), but not in the 
structure of Neisseria meningitidis HO (HemO) (41). Rat and human HO-Is and HmuO have 
a large solvent-accessible distal pocket (Figure 7-2) (44.9 A3 for rat HO-1, 43.6-59.7 A3 for 
human HO-1, 23.2-27.6 A3 for HmuO), in contrast, hat of HemO is very narrow (7.5 A3). 
The slightly elongated shape of the density at the site-2 (Figure 7-Ib) suggests that it is 
derived from CO. Although the possibility that water is bound to site-2 cannot be excluded 
based on the difference map at this resolution, it would be unlikely because of the high 
hydrophobicity of the site. Moreover, no such density was observed at site-2 in a similar 
experiment conducted with a crystal of heme-HO bound to CN- (pH 6.8), although CN" was 
photodissociated by laser irradiation (Figure 7-3). This finding suggests that the molecular 
species occupying site-2 in CO-heme-HO is itself hydrophobic. A series of similar 
experiments with Mb and Hb (119-124) have confirmed that CO dissociated upon photolysis 
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is temporarily trapped in the hydrophobic avity, consistent with our findings with 
CO-heme-HO. The possibility that he CO generated in the HO reaction escapes into the inner 
hydrophobic chamber has been raised in the analysis conducted with human heme-HO (40). 
Thus, we conclude that he photodissociated CO is temporarily trapped in site-2. The present 
study has reveled that CO dissociated upon irradiation with laser light is trapped at site-2, 
major site, and site-1, minor site. Our preliminary estimate of CO occupancies showed that 
about 15% of CO bound to the heme iron was dissociated from heme-HO by laser irradiation 
and that about 5% and 10% of CO were trapped at site-1 and site-2, respectively. 
    Site-1 may indicate the travelling pathway to the site-2 of the CO released from 
CO-heme-HO or the CO formed in the HO reaction. However, trapping CO at the site-2 needs 
that apolar CO goes through the space occupyied by water molecules forming the rigid 
hydrogen bonding network, which may need to overcome the large energy barrier. To verify 
this process, I carried out the molecular dynamics imulation of CO migration in the 
hemepocket of heme-HO. Predicted pathway of CO in hemepocket was consistent to the CO 
trapping at site-2 (Figure 7-4); CO reached to the site-2 and trapped. 
    Trapping CO at site-2 would free from inhibition of 02 incorporation by CO in the 
conversion step of verdoheme to biliverdin IXa (Figure 1-3). When iron and biliverdin are 
released from HO, CO would be readily released from site-2; in the case of rat HO-1, site-2 in 
the apo state is fully exposed to solvent (90). The affinity of CO for verdoheme-HO is 10,000 
times weaker than that for heme-HO (35). Thus, conceivably, binding of the endogenously 
produced CO to verdoheme-HO would be retarded by trapping CO at site-2.
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Figure 7-1. Stereoviews of the difference Fourier map of CO-heme-HO between the 
dark and laser light-irradiated conditions. a. The difference Fourier map (red; -3.5(y, 
blue; +3.56) is superimposed on the ball-and-stick model. Heme is colored green for 
clarity. Positive and negative densities indicate the densities that were increased and 
decreased, respectively, upon laser irradiation. b. The difference Fourier map (cyan; -3.0(7) 
is superimposed on the ball-and-stick model around site-2. Only the protein side-chains 
are shown for clarity. These figures were prepared with MOLSCRIPT (125), 
CONSCRIPT (127), and RASTER3D (126).
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Figure 7-2. Solvent-accessible cavity of rat CO-heme-HO. The solvent-accessible cavity 
on the distal side of the heme moeity is superimposed on the ribbon diagram of rat 
CO-heme-HO. The letters indicate the appropriate helices in rat heme-HO. Heme and axial 
ligands are shown as ball-and-stick models. The accessible cavity is colored green. This 
figure was prepared with MOLSCRIPT (125), CONSCRIPT (127), and RASTER3D 
(126).
Figure 7-3. The 
difference Fourier map 
of CN-heme-HO 
between the dark and 
laser light-irradiated 
conditions. 
Represantation method 
of this figure is same to 
that of figure 7-1 a. Red 
density on the heme iron 
indicates the photolysis 
of CN--heme-HO, while 
no siginificant density 
was appeared at the 
site-2. These figures 
were prepared with 
MOLSCRIPT (125), 
CONSCRIPT (127), and 
RASTER3D (126).
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Figure 7-4. Snapshots of molecular dynamics simulation of CO migration. Heme, 
Met-51, Val-50, and CO (orange) were shown in ball-and-stick model. Other moiety was 
shown in ribbon diagram. After 33 ps from starting the simulation, CO was diffused and 
trapped in the site-2. Sometimes CO came back near the heme, but almost all times in the 
simulation CO was trapped in the site-2. This figure was prepared with VMD (130). 
    Protein and water motions on the photolysis of CO. Structuralcomparison of 
CO-heme-HO and ferrous heme-HO indicates that heme and the distal helix shift to opposite 
direction upon CO binding to the heme iron (114). However, the structural changes brought 
about by CO binding were not restored to the original state on the photolysis of CO at the 
cryogenic temperature. Because neither of the distal helix nor the heme is involved in 
intermolecular contact, crystal packing force will not restrict the movements. The 
rearrangements of heme and the proximal helix have been detected in Hb (124) under the 
experimental conditions similar to those of our study, indicating that rapid protein motions 
can be detected even in the cryogenic temperature. Thus, no significant movement of heme 
and distal helix on the photolysis of CO-heme-HO at the cryogenic temperature suggests the 
movements of heme and the distal helix are slow and/or a high-energy barrier lies between the 
two structures. Indeed, the diffraction data re-measured for the photolyzed crystal stocked in 
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liquid nitrogen for four months showed the heme iron shifted to the corresponding site in 
ferrous heme-HO. 
    On the other hand, water molecules involved in hydrogen bond network, which is 
considered to be the proton pathway to activate molecular oxygen bound to heme iron, were 
slightly fluctuated judged from the positive densities observed at the water sites in the 
difference Fourier map (Figure 7-la). This could be interpreted as a result of disruption of the 
hydrogen bond between the oxygen atom of CO and one water molecule upon dissociation of 
CO from the heme. Similar fluctuation of the water molecules is observed in ferrous 
heme-HO, wherein the distal igand of the heme is absent (114).
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2.4 Conclusions 
    Thestructures of various ligand bound forms of heme-HO complexes demonstrate the 
structural basis for the discrimination of 02 against CO in HO. Inherently, CO prefers 
tilt-binding to the heme iron and 02 prefers bent-binding. Narrowness of HO hemepocket , 
which is essential for regiospecific reaction of HO, would cause the steric hindrance of CO 
binding but not 02 binding. On CO binding to heme-HO, this hindrance is avoided by heme 
and distal helix shifts. However, this structural change is accompanied with the disruption of 
the salt-bridge stabilizing heme position. In addition, 02 binding would be stabilized by two 
hydrogen bonds, contributed by the amide group of Gly-143 and water, whereas only one 
water molecule is hydrogen-bonded to CO bound to the heme. In addition, the polar nature of 
HO hemepocket would increase the 02 affinity. The alternative cyanide binding mode 
depending on pH may indicate that the energy loss of the heme and distal helix shifts is 
comparable tothat of the bent-binding of cyanide. The static discrimination between 02 and 
CO in HO is achieved by the binding mode difference between 02 and CO. 
    Moreover, the cryo-trapped structure of the photolysis of CO-heme-HO has shown that 
CO dissociated by laser irradiation istrapped in the hydrophobic cavity which is located 10 A 
from the heme iron. The CO trapping would retard CO binding to verdoheme and facilitate 02 
binding which is indispensable for the conversion step of verdoheme to biliverdin IXa. 
Dynamic discrimination between 02 and CO in HO is accomplished by the difference of 
hydrophobicity between 02 and CO. These two mechanisms explain how HO escapes from 
the product inhibition by CO.
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